QUARTERLY REPORT

Q3 FY2026 — Quarterly report (Form 10-Q)

Q3 FY2026PDF · 62 pages4.8 MB
Table of Contents
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 10-Q
(Mark one)
☒ 	QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the quarterly period ended March 31, 2026
or
☐ 	TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the transition period from 	to
Commission File Number 000-09992
KLA CORPORATION
(Exact name of registrant as specified in its charter)
Delaware 	04-2564110
(State or other jurisdiction of
incorporation or organization)
(I.R.S. Employer
Identification No.)
One Technology Drive, 	Milpitas, 	California 	95035
(Address of principal executive offices) 	(Zip Code)
(408) 875-3000
(Registrant’s telephone number, including area code)
Securities registered pursuant to Section 12(b) of the Act:
Title of each class 	Trading Symbol(s) 	Name of each exchange on which registered
Common Stock, $0.001 par value per share 	KLAC 	The Nasdaq Stock Market, LLC
The Nasdaq Global Select Market
Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period
that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ☒ No ☐
Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the
preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes ☒ No ☐
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large
accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.
Large accelerated filer 	☒ 	Accelerated filer 	☐
Non-accelerated filer 	☐ 	Smaller reporting company 	☐
Emerging growth company 	☐
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided
pursuant to Section 13(a) of the Exchange Act. ☐
Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ☐ No ☒
As of April 27, 2026, there were 130,627,521 shares of the registrant’s Common Stock, $0.001 par value per share, outstanding.

-- 1 of 62 --

Table of Contents
INDEX
Page
Number
PART I 	FINANCIAL INFORMATION
Item 1. 	Financial Statements (Unaudited)
Condensed Consolidated Balance Sheets as of March 31, 2026 and June 30, 2025 	3
Condensed Consolidated Statements of Operations for the Three Months and Nine Months Ended March 31, 2026 and 2025 	4
Condensed Consolidated Statements of Comprehensive Income for the Three Months and Nine Months Ended March 31, 2026 and 2025 	5
Condensed Consolidated Statements of Stockholders’ Equity for the Three Months and Nine Months Ended March 31, 2026 and 2025 	6
Condensed Consolidated Statements of Cash Flows for the Nine Months Ended March 31, 2026 and 2025 	7
Notes to Condensed Consolidated Financial Statements 	8
Item 2. 	Management’s Discussion and Analysis of Financial Condition and Results of Operations 	34
Item 3. 	Quantitative and Qualitative Disclosures About Market Risk 	46
Item 4. 	Controls and Procedures 	46
PART II 	OTHER INFORMATION
Item 1. 	Legal Proceedings 	48
Item 1A. 	Risk Factors 	48
Item 2. 	Unregistered Sales of Equity Securities and Use of Proceeds 	52
Item 3. 	Defaults Upon Senior Securities 	52
Item 4. 	Mine Safety Disclosures 	53
Item 5. 	Other Information 	53
Item 6. 	Exhibits 	54
SIGNATURES 	55

-- 2 of 62 --

Table of Contents
PART I. FINANCIAL INFORMATION
ITEM 1. FINANCIAL STATEMENTS
KLA CORPORATION
Condensed Consolidated Balance Sheets
(Unaudited)
(In thousands)
March 31,
2026
June 30,
2025
ASSETS
Current assets:
Cash and cash equivalents 	$ 	1,787,010 $ 	2,078,908
Marketable securities 	3,170,928 	2,415,715
Accounts receivable, net 	2,304,454 	2,263,915
Inventories 	3,437,046 	3,212,149
Other current assets 	651,541 	728,102
Total current assets 	11,350,979 	10,698,789
Land, property and equipment, net 	1,363,784 	1,252,775
Goodwill, net 	1,788,483 	1,792,193
Deferred income taxes 	1,123,406 	1,105,770
Purchased intangible assets, net 	300,717 	444,785
Other non-current assets 	946,146 	773,614
Total assets 	$ 	16,873,515 $ 	16,067,926
LIABILITIES AND STOCKHOLDERS’ EQUITY
Current liabilities:
Accounts payable 	$ 	515,009 $ 	458,509
Deferred system revenue 	620,839 	816,834
Deferred service revenue 	576,503 	548,011
Other current liabilities 	2,039,204 	2,262,441
Total current liabilities 	3,751,555 	4,085,795
Long-term debt 	5,887,063 	5,884,257
Deferred tax liabilities 	444,182 	446,945
Deferred service revenue 	251,563 	348,844
Other non-current liabilities 	708,657 	609,632
Total liabilities 	11,043,020 	11,375,473
Commitments and contingencies (Notes 8, 13 and 14)
Stockholders’ equity:
Common stock and capital in excess of par value 	2,675,013 	2,511,922
Retained earnings 	3,187,462 	2,179,330
Accumulated other comprehensive income (loss) 	(31,980) 	1,201
Total stockholders’ equity 	5,830,495 	4,692,453
Total liabilities and stockholders’ equity 	$ 	16,873,515 $ 	16,067,926
See accompanying notes to Condensed Consolidated Financial Statements (unaudited).

-- 3 of 62 --

Table of Contents
KLA CORPORATION
Condensed Consolidated Statements of Operations
(Unaudited)
Three Months Ended March 31, 	Nine Months Ended March 31,
(In thousands, except per share amounts) 	2026 	2025 	2026 	2025
Revenues:
Product 	$ 	2,640,287 $ 	2,393,821 $ 	7,616,386 $ 	7,000,672
Service 	774,791 	669,208 	2,305,534 	1,980,749
Total revenues 	3,415,078 	3,063,029 	9,921,920 	8,981,421
Costs and expenses:
Costs of revenues 	1,327,672 	1,175,689 	3,841,952 	3,544,581
Research and development 	388,763 	338,043 	1,133,095 	1,007,345
Selling, general and administrative 	291,134 	248,905 	840,041 	767,028
Impairment of goodwill and purchased intangible assets 	— 	— 	— 	239,100
Interest expense 	70,423 	71,889 	211,166 	229,041
Other expense (income), net 	(79,675) 	(35,930) 	(160,874) 	(121,323)
Income before income taxes 	1,416,761 	1,264,433 	4,056,540 	3,315,649
Provision for income taxes 	215,771 	176,017 	588,828 	456,855
Net income 	$ 	1,200,990 $ 	1,088,416 $ 	3,467,712 $ 	2,858,794
Net income per share
Basic 	$ 	9.17 $ 	8.21 $ 	26.41 $ 	21.44
Diluted 	$ 	9.12 $ 	8.16 $ 	26.26 $ 	21.32
Weighted-average number of shares:
Basic 	130,909 	132,607 	131,318 	133,361
Diluted 	131,750 	133,303 	132,073 	134,066
See accompanying notes to Condensed Consolidated Financial Statements (unaudited).

-- 4 of 62 --

Table of Contents
KLA CORPORATION
Condensed Consolidated Statements of Comprehensive Income
(Unaudited)
Three Months Ended March 31, 	Nine Months Ended March 31,
(In thousands) 	2026 	2025 	2026 	2025
Net income 	$ 	1,200,990 $ 	1,088,416 $ 	3,467,712 $ 	2,858,794
Other comprehensive income (loss):
Currency translation adjustments:
Cumulative currency translation adjustments 	(12,379) 	4,259 	(8,436) 	(765)
Income tax (provision) benefit 	498 	(104) 	(146) 	750
Net change related to currency translation adjustments 	(11,881) 	4,155 	(8,582) 	(15)
Cash flow hedges:
Net unrealized gains (losses) arising during the period 	(270) 	(1,851) 	15,499 	3,136
Reclassification adjustments for net gains included in net income 	(14,265) 	(1,292) 	(38,645) 	(7,060)
Income tax benefit 	2,261 	628 	4,515 	1,723
Net change related to cash flow hedges 	(12,274) 	(2,515) 	(18,631) 	(2,201)
Net change related to unrecognized gains (losses) and transition obligations in
connection with defined benefit plans 	394 	(209) 	672 	366
Available-for-sale securities:
Net unrealized gains (losses) arising during the period 	(11,520) 	2,967 	(7,974) 	10,573
Reclassification adjustments for net gains included in net income 	(170) 	(9) 	(482) 	(9)
Income tax (provision) benefit 	2,511 	(636) 	1,816 	(2,272)
Net change related to available-for-sale securities 	(9,179) 	2,322 	(6,640) 	8,292
Other comprehensive income (loss) 	(32,940) 	3,753 	(33,181) 	6,442
Total comprehensive income 	$ 	1,168,050 $ 	1,092,169 $ 	3,434,531 $ 	2,865,236
See accompanying notes to Condensed Consolidated Financial Statements (unaudited).

-- 5 of 62 --

Table of Contents
KLA CORPORATION
Condensed Consolidated Statements of Stockholders’ Equity
(Unaudited)
Common Stock and
Capital in Excess of
Par Value 	Retained
Earnings
Accumulated
Other
Comprehensive
Income (Loss)
Total
Stockholders’
Equity	(In thousands, except per share amounts) 	Shares 	Amount
Balances as of June 30, 2025 	132,023 $ 	2,511,922 $ 	2,179,330 $ 	1,201 $ 	4,692,453
Net income 	— 	— 	1,121,040 	— 	1,121,040
Other comprehensive loss 	— 	— 	— 	(530) 	(530)
Net issuance under employee stock plans 	116 	(81,122) 	— 	— 	(81,122)
Repurchase of common stock 	(623) 	(11,861) 	(552,539) 	— 	(564,400)
Cash dividends ($1.90 per share) and dividend equivalents declared 	— 	— 	(252,552) 	— 	(252,552)
Stock-based compensation expense 	— 	70,182 	— 	— 	70,182
Balances as of September 30, 2025 	131,516 	2,489,121 	2,495,279 	671 	4,985,071
Net income 	— 	— 	1,145,682 	— 	1,145,682
Other comprehensive income 	— 	— 	— 	289 	289
Net issuance under employee stock plans 	87 	49,826 	— 	— 	49,826
Repurchase of common stock 	(460) 	(8,717) 	(528,836) 	— 	(537,553)
Cash dividends ($1.90 per share) and dividend equivalents declared 	— 	— 	(251,531) 	— 	(251,531)
Stock-based compensation expense 	— 	73,947 	— 	— 	73,947
Balances as of December 31, 2025 	131,143 	2,604,177 	2,860,594 	960 	5,465,731
Net income 	— 	1,200,990 	— 	1,200,990
Other comprehensive loss 	— 	— 	— 	(32,940) 	(32,940)
Net issuance under employee stock plans 	7 	(4,361) 	— 	— 	(4,361)
Repurchase of common stock 	(440) 	(8,741) 	(623,172) 	— 	(631,913)
Cash dividends ($1.90 per share) and dividend equivalents declared 	— 	— 	(250,950) 	— 	(250,950)
Stock-based compensation expense 	— 	83,938 	— 	— 	83,938
Balances as of March 31, 2026 	130,710 $ 	2,675,013 $ 	3,187,462 $ 	(31,980) $ 	5,830,495
Common Stock and
Capital in Excess of
Par Value 	Retained
Earnings
Accumulated
Other
Comprehensive
Income (Loss)
Total
Stockholders’
Equity	(In thousands, except per share amounts) 	Shares 	Amount
Balances as of June 30, 2024 	134,425 $ 	2,280,133 $ 	1,137,270 $ 	(49,075) $ 	3,368,328
Net income 	— 	— 	945,851 	— 	945,851
Other comprehensive income 	— 	— 	— 	23,571 	23,571
Net issuance under employee stock plans 	134 	(72,245) 	— 	— 	(72,245)
Repurchase of common stock 	(740) 	(12,536) 	(558,400) 	— 	(570,936)
Cash dividends ($1.45 per share) and dividend equivalents declared 	— 	— 	(196,555) 	— 	(196,555)
Stock-based compensation expense 	— 	61,700 	— 	— 	61,700
Balances as of September 30, 2024 	133,819 	2,257,052 	1,328,166 	(25,504) 	3,559,714
Net income 	— 	— 	824,527 	— 	824,527
Other comprehensive loss 	— 	— 	— 	(20,882) 	(20,882)
Net issuance under employee stock plans 	104 	43,931 	— 	— 	43,931
Repurchase of common stock 	(979) 	(16,478) 	(639,495) 	— 	(655,973)
Cash dividends ($1.70 per share) and dividend equivalents declared 	— 	— 	(228,609) 	— 	(228,609)
Stock-based compensation expense 	— 	61,841 	— 	— 	61,841
Balances as of December 31, 2024 	132,944 	2,346,346 	1,284,589 	(46,386) 	3,584,549
Net income 	— 	— 	1,088,416 	— 	1,088,416
Other comprehensive income 	— 	— 	— 	3,753 	3,753
Net issuance under employee stock plans 	8 	(2,680) 	— 	— 	(2,680)
Repurchase of common stock 	(711) 	(12,550) 	(499,153) 	— 	(511,703)
Cash dividends ($1.70 per share) and dividend equivalents declared 	— 	— 	(227,797) 	— 	(227,797)
Stock-based compensation expense 	— 	70,201 	— 	— 	70,201
Balances as of March 31, 2025 	132,241 $ 	2,401,317 $ 	1,646,055 $ 	(42,633) $ 	4,004,739
See accompanying notes to Condensed Consolidated Financial Statements (unaudited).

-- 6 of 62 --

Table of Contents
KLA CORPORATION
Condensed Consolidated Statements of Cash Flows
(Unaudited)
Nine Months Ended March 31,
(In thousands) 	2026 	2025
Cash flows from operating activities:
Net income 	$ 	3,467,712 $ 	2,858,794
Adjustments to reconcile net income to net cash provided by operating activities:
Impairment of goodwill and purchased intangible assets 	— 	239,100
Depreciation and amortization 	295,372 	297,836
Unrealized foreign exchange loss and other 	382 	23,622
Stock-based compensation expense 	228,067 	193,742
Net gain on sale of assets 	(683) 	(161)
Deferred income taxes 	(27,254) 	(186,095)
Changes in assets and liabilities:
Accounts receivable 	(55,365) 	(300,289)
Inventories 	(253,659) 	(106,651)
Other assets 	(78,129) 	76,105
Accounts payable 	64,569 	42,390
Deferred system revenue 	(195,991) 	(117,512)
Deferred service revenue 	(68,789) 	64,610
Other liabilities 	(139,583) 	(168,579)
Net cash provided by operating activities 	3,236,649 	2,916,912
Cash flows from investing activities:
Capital expenditures 	(286,657) 	(234,851)
Proceeds from capital-related government assistance 	16,782 	315
Purchases of available-for-sale and equity securities 	(2,850,686) 	(2,024,564)
Proceeds from maturity and sale of available-for-sale securities 	2,113,329 	2,392,560
Purchases of trading securities 	(229,727) 	(88,275)
Proceeds from sale of trading securities 	217,530 	79,384
Other, net 	2,451 	(1,705)
Net cash provided by (used in) investing activities 	(1,016,978) 	122,864
Cash flows from financing activities:
Payment of debt issuance costs 	(1,602) 	—
Repayment of debt 	— 	(750,000)
Common stock repurchases 	(1,718,772) 	(1,724,249)
Payment of dividends to stockholders 	(752,498) 	(650,629)
Issuance of common stock 	55,543 	47,538
Tax withholding payments related to vested and released restricted stock units 	(91,201) 	(78,534)
Net cash used in financing activities 	(2,508,530) 	(3,155,874)
Effect of exchange rate changes on cash and cash equivalents 	(3,039) 	(3,009)
Net decrease in cash and cash equivalents 	(291,898) 	(119,107)
Cash and cash equivalents at beginning of period 	2,078,908 	1,977,129
Cash and cash equivalents at end of period 	$ 	1,787,010 $ 	1,858,022
Supplemental cash flow disclosures:
Income taxes paid, net 	$ 	582,446 $ 	655,822
Interest paid, net of capitalized interest 	$ 	270,586 $ 	284,999
Non-cash activities:
Dividends payable - financing activities 	$ 	6,730 $ 	6,360
Unsettled common stock repurchase - financing activities 	$ 	5,499 $ 	5,499
Accrued purchases of land, property and equipment - investing activities 	$ 	31,941 $ 	24,322
See accompanying notes to Condensed Consolidated Financial Statements (unaudited).
7

-- 7 of 62 --

Table of Contents
KLA CORPORATION
Notes to Condensed Consolidated Financial Statements
(Unaudited)
NOTE 1 – BASIS OF PRESENTATION
Basis of Presentation. For purposes of this report, “KLA,” “Company,” “we,” “our,” “us” or similar references mean KLA Corporation and its majority-owned
subsidiaries unless the context requires otherwise. The Condensed Consolidated Financial Statements have been prepared by us pursuant to the rules and regulations of the U.S.
Securities and Exchange Commission. Certain information and footnote disclosures normally included in financial statements prepared in accordance with accounting
principles generally accepted in the United States of America (“GAAP”) have been condensed or omitted pursuant to such rules and regulations.
The unaudited interim Condensed Consolidated Financial Statements do not include all of the information and footnotes required by GAAP for audited financial
statements. The balance sheet as of June 30, 2025 was derived from the Company’s audited Consolidated Financial Statements included in our Annual Report on Form 10-K for
the fiscal year ended June 30, 2025, but does not include all disclosures required by GAAP for audited financial statements. The unaudited interim Condensed Consolidated
Financial Statements reflect all adjustments (consisting only of normal, recurring adjustments) necessary for a fair statement of the financial position, results of operations,
comprehensive income, stockholders’ equity and cash flows for the periods indicated. These Condensed Consolidated Financial Statements and notes, however, should be read
in conjunction with Item 8 “Financial Statements and Supplementary Data” included in our Annual Report on Form 10-K for the fiscal year ended June 30, 2025.
The Condensed Consolidated Financial Statements include the accounts of KLA and its majority-owned subsidiaries. All significant intercompany balances and
transactions have been eliminated.
The results of operations for the three and nine months ended March 31, 2026 are not necessarily indicative of the results that may be expected for any other interim
period or for the full fiscal year ending June 30, 2026.
Management Estimates. The preparation of the Condensed Consolidated Financial Statements in conformity with GAAP requires management to make estimates and
assumptions in applying our accounting policies that affect the reported amounts of assets and liabilities (and related disclosure of contingent assets and liabilities) at the dates
of the Condensed Consolidated Financial Statements and the reported amounts of revenues and expenses during the reporting periods. Actual results could differ from those
estimates.
Reclassifications. The Company has reclassified certain prior period balances to conform to the current year presentation. These reclassifications did not impact any prior
amounts of reported total assets, total liabilities, stockholders’ equity, results of operations or cash flows.
Significant Accounting Policies. Except for the below change, there have been no changes to our significant accounting policies summarized in Note 1 “Description of
Business and Summary of Significant Accounting Policies” to our Consolidated Financial Statements included in our Annual Report on Form 10-K for the fiscal year ended
June 30, 2025.
Change in Annual Impairment Testing Date. During the second quarter of fiscal 2026, the Company changed the annual goodwill impairment testing date for all
reporting units from February 28 to December 31 to better align with the timing of our budgeting and strategic planning process. We believe that the change in our annual
impairment test date is preferable as it allows us to evaluate any potential impact strategic decisions may have on the recoverability of goodwill as those decisions are reached.
This will also enable us to use the most current information available in the assessment process. The change in the annual impairment testing date did not delay, accelerate or
avoid an impairment charge.
Recent Accounting Pronouncements
Recently Adopted
In November 2023, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU”) 2023-07, Segment Reporting (Topic 280),
Improvements to Reportable Segment Disclosures. The new guidance requires enhanced disclosures about significant segment expenses. This standard update is effective for
our annual reports beginning in the fiscal year ended June 30, 2025, and interim period reports beginning in the first quarter of the fiscal year ending June 30, 2026. We adopted
ASU 2023-07 starting with our annual report for the fiscal year ended June 30, 2025, for annual reporting and from July 1, 2025, for interim periods on a retrospective basis.
In September 2025, the FASB issued ASU 2025-06, Intangibles - Goodwill and Other - Internal-Use Software (Subtopic

-- 8 of 62 --

Table of Contents
350-40): Targeted Improvements to the Accounting for Internal-Use Software. The new guidance removes all references to prescriptive and sequential software development
stages or project stages throughout Subtopic 350-40. Therefore, an entity is required to start capitalizing software costs when management has authorized and committed to
funding the software project and it is probable that the project will be completed, and the software will be used to perform the function intended. The standard update is
effective for our annual and interim reports beginning in the first quarter of our fiscal year ending June 30, 2028. Early adoption is permitted as of the beginning of an annual
reporting period. We adopted ASU 2025-06 for our first quarter of the fiscal year ending June 30, 2026 using a prospective transition approach, and the effect was immaterial to
our Consolidated Financial Statements.
In July 2025, the FASB issued ASU 2025-05, Financial Instruments – Credit Losses (Topic 326), Measurement of Credit Losses for Accounts Receivable and Contract
Assets. The ASU provides a practical expedient to measure credit losses on current accounts receivable and contract assets arising from transactions accounted for under ASC
606. This practical expedient allows companies to assume the current conditions as of the balance sheet date do not change for the remaining life of the current accounts
receivable and current contract assets. The standard update is effective for our annual and interim reports beginning in the first quarter of our fiscal year ending June 30, 2027.
The amendments in this ASU should be applied on a prospective basis and early adoption is permitted. We chose to early adopt ASU 2025-05 during the quarter ended March
31, 2026, and elected the practical expedient. Since we adopted it in an interim reporting period, we are required to apply the amendments as of the beginning of the annual
reporting period containing this interim reporting period. The adoption did not have a material impact on our Consolidated Financial Statements or related disclosures.
Updates Not Yet Effective
In December 2023, the FASB issued ASU 2023-09, Income Taxes (Topic 740), Improvements to Income Tax Disclosures. The new guidance requires enhanced disclosures
about income tax expenses. This standard update is effective for our annual reports beginning in the fiscal year ending June 30, 2026. The amendments in this ASU will be
applied on a prospective basis. Adoption of this new guidance will result in expanded disclosures in the Notes to the Consolidated Financial Statements.
In November 2024, the FASB issued ASU 2024-03, Income Statement – Reporting Comprehensive Income – Expense Disaggregation Disclosures (Subtopic 220-40):
Disaggregation of Income Statement Expenses. The new guidance requires enhanced disclosures about certain expenses in the notes to the financial statements to provide
enhanced transparency into the expense captions presented on the face of the income statement. In 2025, the FASB issued ASU 2025-01 which clarifies the effective date for
entities that do not have an annual reporting period that ends on December 31st. The Company is required to adopt this standard for our annual reports beginning in the fiscal
year ending June 30, 2028, and interim period reports beginning in the first quarter of the fiscal year ending June 30, 2029. Early adoption is permitted. The amendments in this
ASU should be applied either on a prospective or retrospective basis. We are currently evaluating the impact of this ASU on our disclosures.
In December 2025, the FASB issued ASU 2025-10, Government Grants (Topic 832): Accounting for Government Grants Received by Business Entities. The new
guidance establishes the accounting for a government grant received by a business entity, including guidance for a grant related to an asset and a grant related to income. The
new guidance also requires disclosures, including the nature of the government grant received, the accounting policies used to account for the grant, and significant terms and
conditions of the grant unless legally prohibited from being disclosed. The standard update is effective for our annual and interim reports beginning in the fiscal year ending
June 30, 2030. Early adoption is permitted in both interim and annual reporting periods in which the financial statements have not yet been issued or made available for
issuance. If adopted in an interim reporting period, it must be adopted as of the beginning of the annual reporting period that includes that interim reporting period. The
amendments in this ASU should be applied using a modified prospective, modified retrospective, or retrospective approach. We are currently evaluating the impact of this
guidance on our Consolidated Financial Statements.
NOTE 2 – REVENUE
The following table represents the opening and closing balances of accounts receivable, net, contract assets, long-term accounts receivable, net, and contract liabilities as
of the indicated dates.
As of 	As of
(Dollar amounts in thousands) 	March 31, 2026 	June 30, 2025 	$ Change 	% Change
Accounts receivable, net 	$ 	2,304,454 $ 	2,263,915 $ 	40,539 	2 %
Contract assets 	$ 	100,906 $ 	105,081 $ 	(4,175) 	(4)%
Long-term accounts receivable, net 	$ 	78,210 $ 	— $ 	78,210 	100 %
Contract liabilities 	$ 	1,448,905 $ 	1,713,689 $ 	(264,784) 	(15)%

-- 9 of 62 --

Table of Contents
Our payment terms and conditions vary by contract type, although terms generally include a requirement of payment of 70% to 90% of total contract consideration within
30 to 60 days of shipment, with the remainder payable within 30 days of acceptance.
The change in contract assets during the nine months ended March 31, 2026 was mainly due to $91.1 million of contract assets reclassified to accounts receivable, net, as
our right to consideration for these contract assets became unconditional, partially offset by $87.2 million of revenue recognized for which the payment is subject to conditions
other than passage of time. Contract assets are included in other current assets on our Condensed Consolidated Balance Sheets.
The change in contract liabilities during the nine months ended March 31, 2026 was mainly due the recognition as revenue of $1.18 billion that was included in contract
liabilities as of June 30, 2025, partially offset by an increase in the value of products and services billed to customers for which control of the products and services has not
transferred to the customers. Contract liabilities are included in current liabilities and non-current liabilities, classified as deferred system revenue or deferred service revenue,
on our Condensed Consolidated Balance Sheets.
The following table represents the transaction price for contracts that have not yet been recognized as revenue as of March 31, 2026, which equals our contract liabilities,
and when the Company expects to recognize the amounts as revenue:
(Dollar amounts in thousands) 	Less than 12 months 	12 to 24 months 	24 months or greater 	Total
Contract liabilities 	$ 	1,197,342 $ 	170,588 $ 	80,975 $ 	1,448,905
NOTE 3 – FAIR VALUE MEASUREMENTS
Our financial assets and liabilities are measured and recorded at fair value, except for our debt and certain equity investments in privately held companies. Equity
investments without a readily available fair value are accounted for using the measurement alternative. The measurement alternative is calculated as cost minus impairment, if
any, plus or minus changes resulting from observable price changes. See Note 7 “Debt” to our Condensed Consolidated Financial Statements for disclosure of the fair value of
our Senior Notes, as defined in that Note.
Our non-financial assets, such as goodwill, intangible assets, and land, property and equipment, are recorded at fair value only if an impairment is recognized in the
current period. We assess for impairment whenever events or changes in circumstances indicate that the carrying value of an asset may not be recoverable. For goodwill, we
assess for impairment annually.
Fair Value of Financial Instruments. We have evaluated the estimated fair value of financial instruments using available market information and valuations as provided
by third-party sources. The use of different market assumptions and/or estimation methodologies could have a significant effect on the estimated fair value amounts. The fair
value of our cash equivalents, accounts receivable, accounts payable and other current assets and liabilities approximate their carrying amounts due to the relatively short
maturity of these items.
Fair Value Hierarchy. The authoritative guidance for fair value measurements establishes a fair value hierarchy that prioritizes the inputs to valuation techniques used to
measure fair value. The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (Level 1 measurements) and the
lowest priority to unobservable inputs (Level 3 measurements). The three levels of the fair value hierarchy are described below:
Level 1 	Valuations based on quoted prices in active markets for identical assets or liabilities that the entity has the ability to access.
Level 2 	Valuations based on quoted prices for similar assets or liabilities, quoted prices in markets that are not active, or other inputs that are
observable or can be corroborated by observable data for substantially the full term of the assets or liabilities.
Level 3 	Valuations based on inputs that are supported by little or no market activity and that are significant to the fair value of the assets or liabilities.
A financial instrument’s level within the fair value hierarchy is based on the lowest level of any input that is significant to the fair value measurement.
The types of instruments valued based on quoted market prices in active markets include money market funds, certain U.S. Treasury securities, U.S. Government agency
securities and equity securities. Such instruments are generally classified within Level 1 of the fair value hierarchy.

-- 10 of 62 --

Table of Contents
The types of instruments valued based on other observable inputs include corporate debt securities, sovereign securities, municipal securities and certain U.S. Treasury
securities. The market inputs used to value these instruments generally consist of market yields, reported trades and broker/dealer quotes. Such instruments are generally
classified within Level 2 of the fair value hierarchy.
The principal market in which we execute our foreign currency contracts is the institutional market in an over-the-counter environment with a relatively high level of
price transparency. The market participants generally are large financial institutions. Our foreign currency contracts’ valuation inputs are based on quoted prices and quoted
pricing intervals from public data sources and do not involve management judgment. These contracts are typically classified within Level 2 of the fair value hierarchy.
Financial assets (excluding cash held in operating accounts and time deposits) and liabilities measured at fair value on a recurring basis, as of the dates indicated below,
were presented on our Condensed Consolidated Balance Sheets as follows:
Quoted Prices in
Active Markets
for Identical Assets
Significant Other
Observable Inputs
As of March 31, 2026 (In thousands) 	Total 	(Level 1) 	(Level 2)
Assets
Cash equivalents:
Corporate debt securities 	$ 	11,623 $ 	— $ 	11,623
Money market funds and other 	1,401,575 	1,401,575 	—
U.S. Treasury securities 	9,949 	— 	9,949
Sovereign securities 	5,045 	— 	5,045
Municipal securities 	4,282 	— 	4,282
Marketable securities:
Corporate debt securities 	1,183,003 	— 	1,183,003
Municipal securities 	34,415 	— 	34,415
Sovereign securities 	46,917 	— 	46,917
U.S. Government agency securities 	98,950 	98,950 	—
U.S. Treasury securities 	1,389,222 	1,286,435 	102,787
Equity securities 	42,799 	42,799 	—
Total cash equivalents and marketable securities 	4,227,780 	2,829,759 	1,398,021
Other current assets:
Derivative assets 	44,220 	— 	44,220
Other non-current assets:
Executive Deferred Savings Plan 	371,868 	356,883 	14,985
Long-term accounts receivable, net 	78,210 	— 	78,210
Total financial assets 	$ 	4,722,078 $ 	3,186,642 $ 	1,535,436
Liabilities
Derivative liabilities 	$ 	(19,394) $ 	— $ 	(19,394)
Total financial liabilities 	$ 	(19,394) $ 	— $ 	(19,394)
________________
(1) Excludes cash of $292.0 million held in operating accounts and time deposits of $438.2 million (of which $62.6 million were cash equivalents) as of March 31, 2026.
(1)
(1)

-- 11 of 62 --

Table of Contents
Quoted Prices in
Active Markets
for Identical Assets
Significant Other
Observable Inputs
As of June 30, 2025 (In thousands) 	Total 	(Level 1) 	(Level 2)
Assets
Cash equivalents:
Municipal securities 	$ 	6,120 $ 	— $ 	6,120
Corporate debt securities 	1,498 	— 	1,498
Money market funds and other 	1,531,022 	1,531,022 	—
U.S. Government agency securities 	9,955 	— 	9,955
U.S. Treasury securities 	9,981 	— 	9,981
Marketable securities:
Corporate debt securities 	960,148 	— 	960,148
Municipal securities 	51,453 	— 	51,453
U.S. Government agency securities 	106,881 	106,881 	—
U.S. Treasury securities 	877,578 	802,682 	74,896
Equity securities 	23,962 	23,962 	—
Total cash equivalents and marketable securities 	3,578,598 	2,464,547 	1,114,051
Other current assets:
Derivative assets 	59,503 	— 	59,503
Other non-current assets:
Executive Deferred Savings Plan 	349,530 	336,090 	13,440
Total financial assets 	$ 	3,987,631 $ 	2,800,637 $ 	1,186,994
Liabilities
Derivative liabilities 	$ 	(28,615) $ 	— $ 	(28,615)
Total financial liabilities 	$ 	(28,615) $ 	— $ 	(28,615)
________________
(1) Excludes cash of $437.8 million held in operating accounts and time deposits of $478.2 million (of which $82.5 million were cash equivalents) as of June 30, 2025.
We did not have any financial assets or liabilities measured at fair value on a recurring basis within Level 3 fair value measurements as of March 31, 2026 or June 30,
2025.
(1)
(1)

-- 12 of 62 --

Table of Contents
NOTE 4 – FINANCIAL STATEMENT COMPONENTS
Condensed Consolidated Balance Sheets
As of 	As of
(In thousands) 	March 31, 2026 	June 30, 2025
Accounts receivable, net:
Accounts receivable, gross 	$ 	2,362,503 $ 	2,297,930
Allowance for credit losses 	(58,049) 	(34,015)
$ 	2,304,454 $ 	2,263,915
Inventories:
Customer service parts 	$ 	602,543 $ 	600,769
Raw materials 	1,648,430 	1,491,786
Work-in-process 	929,604 	833,933
Finished goods 	256,469 	285,661
$ 	3,437,046 $ 	3,212,149
Other current assets:
Prepaid expenses 	$ 	173,576 $ 	201,053
Deferred costs of revenues 	172,014 	223,829
Contract assets 	100,906 	105,081
Prepaid income and other taxes 	63,958 	64,704
Other current assets 	141,087 	133,435
$ 	651,541 $ 	728,102
Land, property and equipment, net:
Land 	$ 	86,654 $ 	86,677
Buildings and leasehold improvements 	1,236,963 	1,132,176
Machinery and equipment 	1,373,586 	1,238,599
Office furniture and fixtures 	80,482 	73,993
Construction-in-process 	220,756 	207,807
2,998,441 	2,739,252
Less: accumulated depreciation 	(1,634,657) 	(1,486,477)
$ 	1,363,784 $ 	1,252,775
Other non-current assets:
Executive Deferred Savings Plan 	$ 	371,868 $ 	349,530
Operating lease right of use assets 	332,287 	269,714
Long-term accounts receivable, net 	78,210 	—
Other non-current assets 	163,781 	154,370
$ 	946,146 $ 	773,614
Other current liabilities:
Compensation and benefits 	$ 	470,913 $ 	418,515
Customer deposits 	411,202 	636,369
Executive Deferred Savings Plan 	374,437 	350,426
Income taxes payable 	117,231 	167,262
Operating lease liabilities 	51,146 	45,192
Interest payable 	48,253 	110,056
Other liabilities and accrued expenses 	566,022 	534,621
$ 	2,039,204 $ 	2,262,441
Other non-current liabilities:
Income taxes payable 	$ 	254,498 $ 	221,808
Operating lease liabilities 	207,151 	158,833
Pension liabilities 	48,043 	51,750
Customer deposits 	9,653 	6,823
Other non-current liabilities 	189,312 	170,418
$ 	708,657 $ 	609,632
(1)
(1)

-- 13 of 62 --

Table of Contents
________________
(1) 	We have a non-qualified deferred compensation plan (known as the “Executive Deferred Savings Plan” or “EDSP”) under which certain employees and non-employee
directors may defer a portion of their compensation. The expense (benefit) associated with changes in the EDSP liability included in selling, general and administrative
(“SG&A”) was $(8.8) million and $(7.9) million in the three months ended March 31, 2026 and 2025, respectively, and was $15.8 million and $13.4 million during the
nine months ended March 31, 2026 and 2025, respectively. The amount of net gains (losses) associated with changes in the EDSP assets included in SG&A expense was
$(9.0) million and $(9.1) million in the three months ended March 31, 2026 and 2025, respectively, and was $15.4 million and $12.3 million during the nine months
ended March 31, 2026 and 2025, respectively. For additional details, refer to Note 1 “Description of Business and Summary of Significant Accounting Policies” to our
Consolidated Financial Statements included in our Annual Report on Form 10-K for the fiscal year ended June 30, 2025.
Accumulated Other Comprehensive Income (Loss)
The components of Accumulated Other Comprehensive Income (Loss) (“AOCI”) as of the dates indicated below were as follows:
(In thousands)
Currency Translation
Adjustments
Unrealized Gains (Losses)
on Available-for-Sale
Securities
Unrealized Gains
(Losses) on Derivatives
Unrealized Gains
(Losses) on Defined
Benefit Plans 	Total
Balance as of March 31, 2026 	$ 	(65,859) $ 	(848) $ 	46,167 $ 	(11,440) $ 	(31,980)
Balance as of June 30, 2025 	$ 	(57,277) $ 	5,792 $ 	64,798 $ 	(12,112) $ 	1,201
The effects on net income of amounts reclassified from AOCI to the Condensed Consolidated Statements of Operations for the indicated periods were as follows (in
thousands; amounts in parentheses indicate debits or reductions to earnings):
AOCI Components
Three Months Ended 	Nine Months Ended
Location in the Condensed Consolidated Statement of Operations
March 31, 	March 31,
2026 	2025 	2026 	2025
Unrealized gains (losses) on cash flow hedges
from foreign exchange and interest rate
contracts 	Revenues 	$ 	2,071 $ 	2,680 $ 	4,474 $ 	6,226
Costs of revenues and operating expenses 	11,436 	(2,146) 	31,896 	(1,692)
Interest expense 	758 	758 	2,275 	2,526
Net gains reclassified from AOCI 	$ 	14,265 $ 	1,292 $ 	38,645 $ 	7,060
Unrealized gains on available-for-sale securities Other expense (income), net 	$ 	170 $ 	9 $ 	482 $ 	9

-- 14 of 62 --

Table of Contents
NOTE 5 – MARKETABLE SECURITIES
The amortized cost and fair value of our fixed income marketable securities as of the dates indicated below were as follows:
As of March 31, 2026 (In thousands)
Amortized
Cost
Gross
Unrealized
Gains
Gross
Unrealized
Losses
Fair
Value
Corporate debt securities 	$ 	1,194,203 $ 	1,851 $ 	(1,428) $ 	1,194,626
Money market funds and other 	1,401,575 	— 	— 	1,401,575
Municipal securities 	38,648 	54 	(5) 	38,697
Sovereign securities 	51,985 	— 	(23) 	51,962
U.S. Government agency securities 	98,771 	265 	(86) 	98,950
U.S. Treasury securities 	1,400,879 	1,365 	(3,073) 	1,399,171
Subtotal 	4,186,061 	3,535 	(4,615) 	4,184,981
Add: Time deposits 	438,179 	— 	— 	438,179
Less: Cash equivalents 	1,495,035 	— 	(4) 	1,495,031
Marketable securities 	$ 	3,129,205 $ 	3,535 $ 	(4,611) $ 	3,128,129
As of June 30, 2025 (In thousands)
Amortized
Cost
Gross
Unrealized
Gains
Gross
Unrealized
Losses Fair
Value
Corporate debt securities 	$ 	957,256 $ 	4,456 $ 	(66) $ 	961,646
Money market funds and other 	1,531,022 	— 	— 	1,531,022
Municipal securities 	57,445 	129 	(1) 	57,573
U.S. Government agency securities 	116,436 	458 	(58) 	116,836
U.S. Treasury securities 	885,101 	2,787 	(329) 	887,559
Subtotal 	3,547,260 	7,830 	(454) 	3,554,636
Add: Time deposits 	478,191 	— 	— 	478,191
Less: Cash equivalents 	1,641,074 	1 	(1) 	1,641,074
Marketable securities 	$ 	2,384,377 $ 	7,829 $ 	(453) $ 	2,391,753
________________
(1) Time deposits excluded from fair value measurements.
(2) Excludes equity marketable securities.
Our investment portfolio includes both corporate and government securities that have a maximum maturity of three years. The longer the duration of these securities, the
more susceptible they are to changes in market interest rates and bond yields. As yields increase, those securities with a lower yield-at-cost show a mark-to-market unrealized
loss. Most of our unrealized losses are due to changes in market interest rates and bond yields. We believe that we have the ability to realize the full value of all these
investments upon maturity. As of March 31, 2026, we had 448 investments in a gross unrealized loss position. The following table summarizes the fair value and gross
unrealized losses of our investments that were in an unrealized loss position as of the dates indicated below.
As of March 31, 2026 	Less than 12 Months 	12 Months or Greater 	Total
(In thousands) 	Fair Value
Gross
Unrealized
Losses 	Fair Value
Gross
Unrealized
Losses 	Fair Value
Gross
Unrealized
Losses
Corporate debt securities 	$ 	510,703 $ 	(1,428) $ 	— $ 	— $ 	510,703 $ 	(1,428)
Municipal securities 	10,794 	(5) 	— 	— 	10,794 	(5)
Sovereign securities 	51,962 	(23) 	— 	— 	51,962 	(23)
U.S. Government agency securities 	38,937 	(86) 	— 	— 	38,937 	(86)
U.S. Treasury securities 	883,043 	(3,073) 	— 	— 	883,043 	(3,073)
Total 	$ 	1,495,439 $ 	(4,615) $ 	— $ 	— $ 	1,495,439 $ 	(4,615)
(1)
(2)
(1)
(2)

-- 15 of 62 --

Table of Contents
As of June 30, 2025 	Less than 12 Months 	12 Months or Greater 	Total
(In thousands) 	Fair Value
Gross
Unrealized
Losses 	Fair Value
Gross
Unrealized
Losses 	Fair Value
Gross
Unrealized
Losses
Corporate debt securities 	$ 	98,149 $ 	(63) $ 	2,528 $ 	(3) $ 	100,677 $ 	(66)
Municipal securities 	5,774 	(1) 	— 	— 	5,774 	(1)
U.S. Government agency securities 	32,780 	(58) 	— 	— 	32,780 	(58)
U.S. Treasury securities 	238,627 	(297) 	20,330 	(32) 	258,957 	(329)
Total 	$ 	375,330 $ 	(419) $ 	22,858 $ 	(35) $ 	398,188 $ 	(454)
The contractual maturities of securities classified as available-for-sale, regardless of their classification on our Condensed Consolidated Balance Sheets, as of the date
indicated below were as follows:
As of March 31, 2026 (In thousands) 	Amortized Cost 	Fair Value
Due within one year 	$ 	1,464,028 $ 	1,465,331
Due after one year through three years 	1,665,177 	1,662,798
Total 	$ 	3,129,205 $ 	3,128,129
Actual maturities may differ from contractual maturities because borrowers may have the right to call or prepay obligations with or without call or prepayment penalties.
Realized gains and losses on available-for-sale securities for the three and nine months ended March 31, 2026 and 2025 were immaterial.
The costs for our equity marketable securities were $22.9 million as of both March 31, 2026, and June 30, 2025. Unrealized gains and losses for our equity marketable
securities for the three and nine months ended March 31, 2026 and 2025 were immaterial.
NOTE 6 – GOODWILL AND PURCHASED INTANGIBLE ASSETS
Goodwill
Goodwill represents the excess of the purchase price over the fair value of the net tangible and identifiable intangible assets acquired in business combinations.
The following table presents changes in goodwill carrying value by reportable segment during the nine months ended March 31, 2026:
(In thousands)
Semiconductor Process
Control 	Specialty Semiconductor Process
Printed Circuit Board (“PCB”)
and Component Inspection 	Total
Balances as of June 30, 2025 	$ 	759,885 $ 	681,858 $ 	350,450 $ 	1,792,193
Foreign currency adjustments 	(1,452) 	(816) 	(1,442) 	(3,710)
Balances as of March 31, 2026 	$ 	758,433 $ 	681,042 $ 	349,008 $ 	1,788,483
As of March 31, 2026, and June 30, 2025, goodwill is net of accumulated impairment losses of $277.6 million and $70.5 million in the Semiconductor Process Control
and PCB and Component Inspection reportable segments, respectively.
Goodwill is not subject to amortization but is tested for impairment annually, as well as whenever events or changes in circumstances indicate that the carrying value
may not be recoverable. In testing goodwill for impairment, we utilize a qualitative assessment to evaluate whether it is more likely than not that the fair value of a reporting
unit is less than its carrying amount. When performing the qualitative assessment, we consider the following factors: stock price or market capitalization, changes in the
industry and competitive environment, budget-to-actual revenue and profitability performance from the prior year and projected revenue and profitability trends for future years
at our reporting units. If our qualitative assessment indicates that goodwill impairment is more likely than not, we perform a quantitative assessment by comparing the carrying
value to the fair value of the reporting units. If the fair value is determined to be less than the carrying value, the amount of impairment is computed as the excess of the
carrying value over the estimated fair value, not to exceed the carrying value of goodwill. Any impairment charges could have a material adverse effect on our operating results
and net asset value in the quarter in which we recognize the impairment charge.

-- 16 of 62 --

Table of Contents
As of March 31, 2026, there have been no significant events or circumstances affecting the valuation of goodwill subsequent to the annual assessment performed in the
second quarter of the fiscal year 2026.
During the second quarter of fiscal 2025, in connection with our annual strategic planning process, we noted a continued deterioration of the long-term forecast for our
PCB business, which is part of our PCB and Component Inspection reportable segment. In addition, in the second quarter of fiscal 2025, we completed an internal
reorganization affecting the composition of reporting units within our Specialty Semiconductor Process and PCB and Component Inspection reportable segments. The
downward revision of financial outlook for PCB and the reorganization of reporting units triggered goodwill impairment tests. As a result of our quantitative assessment before
reorganization, we recorded a total goodwill impairment charge of $230.4 million in the former PCB reporting unit, which was part of the PCB and Component Inspection
reportable segment, in the second quarter of fiscal 2025. No goodwill impairment was identified in the Specialty Semiconductor Process reportable segment. We assessed for
impairment subsequent to the reorganization and noted no impairment. The goodwill balances of our new reporting units after reorganization were allocated on a relative fair
value basis.
To determine the fair value of a reporting unit, we utilized income and market approaches and applied weighting of 75 percent and 25 percent, respectively. The
income approach is estimated through discounted cash flow analysis. This valuation technique requires us to use significant estimates and assumptions, including long-term
growth rates, discount rates and other inputs. The market approach estimates the fair value of the reporting unit by utilizing the market comparable method, which is based on
revenue and earnings multiples from comparable companies. There can be no assurance that these estimates and assumptions will prove to be an accurate prediction of the
future, and a downward revision of these estimates and/or assumptions would decrease the fair value of our reporting units, which could result in additional impairment charges
in the future.
Purchased Intangible Assets
Changes in the gross carrying amount of intangible assets result from changes in foreign currency exchange rates and acquisitions. The components of purchased
intangible assets as of the dates indicated below were as follows:
(In thousands) 	As of March 31, 2026 	As of June 30, 2025
Category
Gross
Carrying
Amount
Accumulated
Amortization
and
Impairment Net
Amount
Gross
Carrying
Amount
Accumulated
Amortization
and
Impairment Net
Amount
Existing technology 	$ 	1,555,974 $ 	1,334,803 $ 	221,171 $ 	1,555,688 $ 	1,222,520 $ 	333,168
Customer relationships 	358,036 	309,616 	48,420 	359,555 	285,274 	74,281
Trade name / Trademark 	119,346 	119,346 	— 	119,409 	113,210 	6,199
Order backlog and other 	91,100 	85,021 	6,079 	89,309 	84,419 	4,890
Intangible assets subject to amortization 	2,124,456 	1,848,786 	275,670 	2,123,961 	1,705,423 	418,538
In-process research and development 	44,874 	19,827 	25,047 	46,074 	19,827 	26,247
Total 	$ 	2,169,330 $ 	1,868,613 $ 	300,717 $ 	2,170,035 $ 	1,725,250 $ 	444,785
Purchased intangible assets are reviewed for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset or asset group may
not be fully recoverable. Impairment indicators primarily include declines in our operating cash flows from the use of these assets. If impairment indicators are present, we are
required to perform a recoverability test by comparing the sum of the estimated undiscounted future cash flows attributable to these long-lived assets to their carrying value.
As of March 31, 2026, there were no impairment indicators for purchased intangible assets.
In connection with the evaluation of the goodwill impairment in the PCB and Component Inspection reportable segment during the second quarter of fiscal 2025, due to
the continued deterioration of financial outlook for the businesses and internal reorganization both noted above, the Company assessed tangible and intangible assets for
impairment prior to performing the goodwill impairment test. The Company first performed a recoverability test for each asset group identified in the PCB and Component
Inspection reportable segment by comparing projected undiscounted cash flows from the use and eventual disposition of each asset group to its carrying value. This test
indicated that the undiscounted cash flows were not sufficient to recover the carrying value of the asset groups. We then compared the carrying value of the individual long-
lived assets within those asset groups against their fair value in order to measure the impairment loss. As a result of this assessment, we recorded a total purchased intangible
asset impairment charge of $8.7 million. No impairment was identified for other long-lived assets in the second quarter of fiscal 2025.

-- 17 of 62 --

Table of Contents
Total impairment charges for goodwill and purchased intangible assets of $239.1 million were recognized as separate charges and included in income (loss) from
operations in the nine months ended March 31, 2025.
Amortization expense for purchased intangible assets was $47.3 million and $145.8 million for the three and nine months ended March 31, 2026, respectively, and $53.9
million and $169.5 million for the three and nine months ended March 31, 2025, respectively.
Based on the purchased intangible assets gross carrying amount recorded as of March 31, 2026, the remaining estimated annual amortization expense is expected to be as
follows:
Fiscal year ending June 30:
Amortization
(In thousands)
2026 (remaining three months) 	$ 	44,846
2027 	129,024
2028 	49,123
2029 	35,566
2030 	14,760
2031 and thereafter 	2,351
Total 	$ 	275,670
The expected amortization expense is an estimate. Actual amounts of amortization may differ from estimated amounts due to additional intangible asset acquisitions,
changes in foreign currency exchange rates, impairment of intangible assets and other events.
NOTE 7 – DEBT
The following table summarizes our debt as of March 31, 2026 and June 30, 2025:
As of March 31, 2026 	As of June 30, 2025
Amount
(In thousands)
Effective
Interest Rate
Amount
(In thousands)
Effective
Interest Rate
Fixed-rate 4.100% Senior Notes due on March 15, 2029 	$ 	800,000 	4.159 % $ 	800,000 	4.159 %
Fixed-rate 4.650% Senior Notes due on July 15, 2032 	1,000,000 	4.657 % 	1,000,000 	4.657 %
Fixed-rate 4.700% Senior Notes due on February 1, 2034 	500,000 	4.777 % 	500,000 	4.777 %
Fixed-rate 5.650% Senior Notes due on November 1, 2034 	250,000 	5.670 % 	250,000 	5.670 %
Fixed-rate 5.000% Senior Notes due on March 15, 2049 	400,000 	5.047 % 	400,000 	5.047 %
Fixed-rate 3.300% Senior Notes due on March 1, 2050 	750,000 	3.302 % 	750,000 	3.302 %
Fixed-rate 4.950% Senior Notes due on July 15, 2052 	1,450,000 	5.023 % 	1,450,000 	5.023 %
Fixed-rate 5.250% Senior Notes due on July 15, 2062 	800,000 	5.259 % 	800,000 	5.259 %
Total 	5,950,000 	5,950,000
Unamortized discount 	(22,239) 	(23,338)
Unamortized debt issuance costs 	(40,698) 	(42,405)
Total 	$ 	5,887,063 	$ 	5,884,257
Reported as:
Long-term debt 	5,887,063 	5,884,257
Total 	$ 	5,887,063 	$ 	5,884,257
Senior Notes and Debt Redemption
The original discounts on the senior, unsecured long-term notes listed in the table above (collectively, “Senior Notes”) are being amortized over the life of the debt.
Interest is payable semi-annually as follows: on January 15 and July 15 of each year for the Senior Notes due July 15, 2032, 2052, and 2062; on February 1 and August 1 of
each year for the Senior Notes due February 1, 2034; on March 1 and September 1 of each year for the Senior Notes due March 1, 2050; on March 15 and September 15 of each
year for the Senior Notes due March 15, 2029, and 2049; and on May 1 and November 1 of each year for the Senior Notes due November 1, 2034. The Senior Notes rank senior
in right of payment to all of KLA Corporation’s future

-- 18 of 62 --

Table of Contents
subordinated indebtedness, equally in right of payment with all of our existing and future unsecured and unsubordinated indebtedness, are effectively subordinated in right of
payment to all of our future secured indebtedness to the extent of the collateral securing such indebtedness and structurally subordinated in right of payment to all existing and
future indebtedness and other liabilities of the Issuer’s subsidiaries. The relevant indentures for the Senior Notes (collectively, the “Indenture”) include covenants that limit our
ability to grant liens on our facilities and enter into sale and leaseback transactions.
In certain circumstances involving a change of control followed by a downgrade of the rating of a series of Senior Notes by at least two of Moody’s Investors Service,
S&P Global Ratings and Fitch Inc., unless we have exercised our rights to redeem the Senior Notes of such series, we will be required to make an offer to repurchase all or, at
the holder’s option, any part, of each holder’s Senior Notes of that series pursuant to the offer described below (“Change of Control Offer”). In the Change of Control Offer, we
will be required to offer payment in cash equal to 101% of the aggregate principal amount of Senior Notes repurchased plus accrued and unpaid interest, if any, on the Senior
Notes repurchased, up to, but not including, the date of repurchase.
Based on the trading prices of the Senior Notes on the applicable dates, the fair value of the Senior Notes as of March 31, 2026 and June 30, 2025 was $5.46 billion and
$5.54 billion, respectively. While the Senior Notes are recorded at cost, the fair value of the long-term debt was determined based on quoted prices in markets that are not
active; accordingly, the long-term debt is categorized as Level 2 for purposes of the fair value measurement hierarchy.
As of March 31, 2026, we were in compliance with all of our covenants under the Indenture associated with the Senior Notes.
Revolving Credit Facility
On July 3, 2025, we entered into a revolving credit facility (“Revolving Credit Facility”) with a maturity date of July 3, 2030 that allows us to borrow up to $1.50 billion,
pursuant to the terms set forth in the credit agreement (“Credit Agreement”). Subject to the terms of the Credit Agreement, the Revolving Credit Facility may be increased by an
amount up to $500.0 million in the aggregate. As of March 31, 2026, we had no outstanding borrowings under the Revolving Credit Facility.
Under the Revolving Credit Facility, we may borrow, repay and reborrow funds until the maturity date, which may be extended following the exercise of no more than
two one-year extension options with the consent of the lenders. We may prepay outstanding borrowings under the Revolving Credit Facility at any time without a prepayment
penalty.
Borrowings under the Revolving Credit Facility can be made as Term Secured Overnight Financing Rate (“SOFR”) Loans or Alternate Base Rate (“ABR”) Loans, at the
Company’s option. In the event that Term SOFR is unavailable, any Term SOFR elections will be converted to Daily Simple SOFR, as long as it is available. Each Term SOFR
Loan will bear interest at a rate per annum equal to the applicable Adjusted Term SOFR rate, which is equal to the applicable Term SOFR rate plus a spread ranging from 62.5
bps to 100.0 bps, as determined by the Company’s credit ratings at the time. Each ABR Loan will bear interest at a rate per annum equal to the ABR, as determined by the
Company’s credit ratings at the time. We are also obligated to pay an annual commitment fee on the daily undrawn balance of the Revolving Credit Facility, which ranges from
4.0 bps to 10.0 bps, subject to an adjustment in conjunction with changes to our credit rating. The applicable interest rates and commitment fees are also subject to adjustment
based on the Company’s performance against certain environmental sustainability key performance indicators (“KPI”) related to greenhouse gas emissions and renewable
electricity usage. Our performance against these KPIs in calendar year 2024 resulted in reductions to the fees associated with our Revolving Credit Facility. As of March 31,
2026, the applicable commitment fee on the daily undrawn balance of the Revolving Credit Facility was 5.5 bps.
Under the Revolving Credit Facility, the maximum net leverage ratio on a quarterly basis is 3.25 to 1.00, covering the trailing four consecutive fiscal quarters for each
fiscal quarter, which may be increased to 3.75 to 1.00 for a period of time in connection with a material acquisition or a series of material acquisitions. As of March 31, 2026,
our maximum allowed net leverage ratio was 3.25 to 1.00.
We were in compliance with all covenants under the Credit Agreement as of March 31, 2026.
NOTE 8 – LEASES
We have operating leases for facilities, vehicles and other equipment. Our facility leases are primarily used for administrative functions, research and development
(“R&D”), manufacturing, and storage and distribution. Our finance leases are not significant.

-- 19 of 62 --

Table of Contents
Our existing leases do not contain significant restrictive provisions or residual value guarantees; however, certain leases contain provisions for the payment of
maintenance, real estate taxes or insurance costs by us. Our leases have remaining lease terms ranging from less than one year to 27 years, including periods covered by options
to extend the lease when it is reasonably certain that the option will be exercised.
Lease expense was $16.6 million and $44.5 million for the three and nine months ended March 31, 2026, respectively, and $13.1 million and $38.0 million for the three
and nine months ended March 31, 2025, respectively. Expenses related to short-term leases, which were not recorded on the Condensed Consolidated Balance Sheets, were not
material for the three and nine months ended March 31, 2026 and 2025. As of March 31, 2026 and June 30, 2025, the weighted-average remaining lease term was 6.7 and 6.2
years, respectively, and the weighted-average discount rate for operating leases was 3.77% and 4.06% as of March 31, 2026 and June 30, 2025, respectively.
Supplemental cash flow information related to leases was as follows:
Nine Months Ended March 31,
In thousands 	2026 	2025
Operating cash outflows from operating leases 	$ 	41,264 $ 	33,759
Right of use assets obtained in exchange for new operating lease liabilities 	$ 	87,116 $ 	43,369
Maturities of lease liabilities as of March 31, 2026 were as follows:
Fiscal Year Ending June 30: 	(In thousands)
2026 (remaining three months) 	$ 	15,015
2027 	59,001
2028 	49,330
2029 	38,905
2030 	35,153
2031 and thereafter 	98,962
Total lease payments 	296,366
Less imputed interest 	(38,069)
Total 	$ 	258,297
As of March 31, 2026, we did not have material leases that had not yet commenced.
NOTE 9 – EQUITY AND LONG-TERM INCENTIVE COMPENSATION PLANS
As of March 31, 2026, 9.3 million shares remained available for issuance under the KLA Corporation 2023 Incentive Award Plan (“2023 Plan”). In addition, we have an
Employee Stock Purchase Plan (“ESPP”), which enables eligible employees to purchase our common stock. We also offer a cash-based long-term incentive program (“Cash
LTI”) to eligible employees.
For details of the 2023 Plan, ESPP and Cash LTI plans, refer to Note 10 “Equity, Long-Term Incentive Compensation Plans and Non-Controlling Interest” to our
Consolidated Financial Statements included in our Annual Report on Form 10-K for the fiscal year ended June 30, 2025.
Equity Incentive Plans - General Information
The following table summarizes the combined activity under our equity incentive plans:
(In thousands)
Available
For Grant
Balance as of June 30, 2025 	9,574
Restricted stock units granted 	(324)
Restricted stock units granted adjustment 	53
Restricted stock units canceled 	41
Balance as of March 31, 2026 	9,344
(1)
(2)
(3)

-- 20 of 62 --

Table of Contents
__________________
(1) 	The number of restricted stock units (“RSU”) reflects the application of the award multiplier of 2.0x to calculate the impact of the award on the shares reserved under the
2023 Plan.
(2) 	Includes RSUs granted to senior management during the nine months ended March 31, 2026 with performance-based vesting criteria (in addition to service-based
vesting criteria for any of such RSUs that are deemed to have been earned) (“performance-based RSU”). This line item includes all such performance-based RSUs
granted during the nine months ended March 31, 2026 reported at the maximum possible number of shares that may ultimately be issuable if all applicable performance-
based criteria are achieved at their maximum levels and all applicable service-based criteria are fully satisfied (0.1 million shares for the nine months ended March 31,
2026 reflect the application of the multiplier described above).
(3) 	Represents the portion of RSUs granted with performance-based vesting criteria and reported at the actual number of shares issued upon achievement of the performance
vesting criteria during the nine months ended March 31, 2026.
The fair value of stock-based awards is measured at the grant date and is recognized as an expense over the employee’s requisite service period. The fair value for RSUs
granted with “dividend equivalent” rights is determined using the closing price of our common stock on the grant date.
The following table shows stock-based compensation (“SBC”) expense for the indicated periods:
Three Months Ended March 31, 	Nine Months Ended March 31,
(In thousands) 	2026 	2025 	2026 	2025
SBC expense by:
Costs of revenues 	$ 	16,832 $ 	12,875 $ 	42,328 $ 	33,133
R&D 	26,370 	20,726 	69,326 	55,151
SG&A 	40,736 	36,600 	116,413 	105,458
Total SBC expense 	$ 	83,938 $ 	70,201 $ 	228,067 $ 	193,742
SBC capitalized as inventory was $32.5 million and $26.3 million as of March 31, 2026 and June 30, 2025, respectively.
Restricted Stock Units
The following table shows the activity and weighted-average grant date fair values for RSUs during the nine months ended March 31, 2026:
Shares
(In thousands)
Weighted-Average
Grant Date
Fair Value
Outstanding RSUs as of June 30, 2025 	1,292 $ 	536.30
Granted 	162 $ 	933.85
Granted adjustments 	(27) $ 	397.40
Vested and released 	(234) $ 	436.47
Forfeited 	(19) $ 	574.36
Outstanding RSUs as of March 31, 2026 	1,174 $ 	613.65
__________________
(1) 	Share numbers reflect actual shares subject to awarded RSUs.
(2) 	Includes performance-based RSUs.
(3) 	This line item includes performance-based RSUs granted during the nine months ended March 31, 2026 reported at the maximum possible number of shares that may
ultimately be issuable if all applicable performance-based criteria are achieved at their maximum levels and all applicable service-based criteria are fully satisfied (0.1
million shares for the nine months ended March 31, 2026, reflect the application of the multiplier described above).
(4) 	Represents the portion of RSUs granted with performance-based vesting criteria and reported at the actual number of shares issued upon achievement of the performance
vesting criteria during the nine months ended March 31, 2026.
The RSUs granted by us generally vest as follows, in each case subject to the recipient remaining employed by us as of the applicable vesting date: (i) with respect to
awards with only service-based vesting criteria, over periods ranging from two to four years; and (ii) with respect to awards with both performance-based and service-based
vesting criteria, over periods ranging from three to four years. The RSUs granted to the independent members of the Board of Directors vest annually.
(1)
(2)
(3)
(4)
(2)

-- 21 of 62 --

Table of Contents
As of March 31, 2026, the unrecognized SBC expense balance related to RSUs was $436.1 million, excluding the impact of estimated forfeitures, and will be recognized
over an estimated weighted-average amortization period of 1.1 years. The intrinsic value of outstanding RSUs as of March 31, 2026 was $1.73 billion.
NOTE 10 – STOCK REPURCHASE PROGRAM
Our Board of Directors has authorized a program that permits us to repurchase our common stock, including an increase in the authorized repurchase amount of $7.00
billion in the third quarter of fiscal 2026. The stock repurchase program has no expiration date and may be suspended at any time. The intent of the program is, in part, to
mitigate the potential dilutive impact related to our equity incentive plans and shares issued in connection with our ESPP as well as to return excess cash to our stockholders.
Any and all share repurchase transactions are subject to market conditions and applicable legal requirements.
Under the authoritative guidance, share repurchases are recognized as a reduction to retained earnings to the extent available, with any excess recognized as a reduction
of capital in excess of par value. In addition, the Inflation Reduction Act of 2022 introduced a 1% excise tax imposed on certain stock repurchases made after December 31,
2022 by publicly traded companies. The excise tax is recorded as part of the cost basis of treasury stock repurchased after December 31, 2022 and, as such, is included in
stockholders’ equity.
As of March 31, 2026, an aggregate of $10.31 billion of authorization was available for repurchase under the stock repurchase program.
Share repurchases for the indicated periods (based on the trade date of the applicable repurchase) were as follows:
Three Months Ended March 31, 	Nine Months Ended March 31,
(In thousands) 	2026 	2025 	2026 	2025
Number of shares of common stock repurchased 	440 	711 	1,523 	2,430
Total cost of repurchases 	$ 	631,913 $ 	511,703 $ 	1,733,866 $ 	1,738,612
NOTE 11 – NET INCOME PER SHARE
Basic net income per share is calculated by dividing net income available to common stockholders by the weighted-average number of shares of common stock
outstanding during the period. Diluted net income per share is calculated by using the weighted-average number of shares of common stock outstanding during the period,
increased to include the number of additional shares of common stock that would have been outstanding if the shares of common stock underlying our outstanding dilutive
RSUs had been issued. The dilutive effect of outstanding RSUs is reflected in diluted net income per share by application of the treasury stock method.
The following table sets forth the computation of basic and diluted net income per share:
(In thousands, except per share amounts)
Three Months Ended March 31, 	Nine Months Ended March 31,
2026 	2025 	2026 	2025
Numerator:
Net income 	$ 	1,200,990 $ 	1,088,416 $ 	3,467,712 $ 	2,858,794
Denominator:
Weighted-average shares - basic, excluding unvested RSUs 	130,909 	132,607 	131,318 	133,361
Effect of dilutive RSUs and options 	841 	696 	755 	705
Weighted-average shares - diluted 	131,750 	133,303 	132,073 	134,066
Basic net income per share 	$ 	9.17 $ 	8.21 $ 	26.41 $ 	21.44
Diluted net income per share 	$ 	9.12 $ 	8.16 $ 	26.26 $ 	21.32
Anti-dilutive securities excluded from the computation of diluted net income per
share 	— 	5 	1 	39

-- 22 of 62 --

Table of Contents
NOTE 12 – INCOME TAXES
The following table provides details of income taxes:
Three Months Ended March 31, 	Nine Months Ended March 31,
(Dollar amounts in thousands) 	2026 	2025 	2026 	2025
Income before income taxes 	$ 	1,416,761 	$ 	1,264,433 	$ 	4,056,540 	$ 	3,315,649
Provision for income taxes 	$ 	215,771 	$ 	176,017 	$ 	588,828 	$ 	456,855
Effective tax rate 	15.2 % 	13.9 % 	14.5 % 	13.8 %
Our effective tax rate was lower than the U.S. federal statutory rate during the three and nine months ended March 31, 2026, primarily due to the proportion of earnings
generated in jurisdictions with tax rates lower than the U.S. statutory rate and the proportion of U.S. earnings eligible for the Foreign Derived Intangible Income deduction.
In the normal course of business, we are subject to examination by tax authorities throughout the world. We are subject to U.S. federal income tax examinations for all
years beginning from the fiscal year ended June 30, 2022 and are under U.S. federal income tax examination for the fiscal year ended June 30, 2018. We have completed the
federal income tax examination for the fiscal years ended June 30, 2019 and June 30, 2020. We are subject to state income tax examinations for all years beginning from the
fiscal year ended June 30, 2021. We are also subject to examinations in other major foreign jurisdictions, including Singapore and Israel, for all years beginning from the
calendar year ended December 31, 2019. We have completed the audit in Israel for calendar year ended December 31, 2019 to the fiscal year ended June 30, 2022. We believe
our current unrecognized tax benefits are sufficient. It is possible that certain examinations may be concluded in the next 12 months. The timing and resolution of income tax
examinations are uncertain. Given the uncertainty around the timing of the resolution of these ongoing examinations, we are unable to estimate the full range of possible
adjustments to our unrecognized tax benefits within the next 12 months.
Legislative Developments
In January 2026, the Organization for Economic Co-operation and Development’s (“OECD”) introduced two new Pillar Two safe harbors which are expected to be
available for fiscal years beginning on or after January 1, 2026: (1) the Side-by-Side Safe Harbor (“SBSSH”) for multinational entities headquartered in the jurisdictions with
both eligible domestic and worldwide tax systems, and (2) the Ultimate Parent Entity (“UPE”) Safe Harbor for multinational entities with a UPE located in a jurisdiction that
has only an eligible domestic tax system. The U.S. is an eligible jurisdiction for the SBSSH. We are not expecting a material tax impact to our Condensed Consolidated
Financial Statements when countries begin to enact legislation to adopt the SBSSH provisions.
In December 2025, Israel adopted the Pillar Two Global Anti-Base Erosion (“GLoBE”) rules under the Multinational Enterprise (“Minimum Tax”) Act, which includes a
domestic minimum tax of 15% that will be effective for us beginning in the fiscal year ending June 30, 2027. The Pillar Two GLoBE rules are deemed an alternative minimum
tax so we did not recognize any deferred taxes for the estimated effects of the future minimum tax under current GAAP. We are not expecting a material tax impact to our
Condensed Consolidated Financial Statements.
On July 4, 2025, President Trump signed into law the One Big Beautiful Bill Act (“OBBBA”). The OBBBA provides for several permanent changes to the U.S. tax code
among other items, including modifying the Global Intangible Low-Taxed Income and Foreign-Derived Intangible Income rules from the Tax Cuts and Jobs Act; restoring full
expensing for domestic research expenses; and reinstating 100% bonus depreciation provisions. ASC 740, Income Taxes, requires that the tax effects of changes in tax rates and
laws be recognized in the period in which the legislation is enacted. The OBBBA provisions will result in an increase to our cash flows from operating activities and an increase
to our effective tax rate in our fiscal year ending June 30, 2026. The effective tax rate changes have been reflected in the consolidated financial statements for the three and nine
months ended March 31, 2026, and did not have a material impact to our Condensed Consolidated Financial Statements.
In November 2024, Singapore adopted the Pillar Two GLoBE rules under the Minimum Tax Act, which includes a domestic minimum tax of 15% that is effective for us
in the current fiscal year. There was no material impact to our Condensed Consolidated Financial Statements during the three and nine months ended March 31, 2026. The
Pillar Two GLoBE rules are deemed an alternative minimum tax so we did not recognize any deferred taxes for the estimated effects of the future minimum tax under current
GAAP.
California Governor Newsom approved the 2024-25 California State Budget on June 27, 2024, which includes a provision to suspend the use of all net operating losses
and limits the use of R&D tax credits to $5 million for tax years 2024 through 2026. This provision is effective in our fiscal years ended June 30, 2025 through September 30,
2027. There was no

-- 23 of 62 --

Table of Contents
material tax impact to our Condensed Consolidated Financial Statements during the three and nine months ended March 31, 2026.
In December 2021, the OECD’s Inclusive Framework on Base Erosion and Profit Shifting released GLoBE rules under Pillar Two. For the countries that have enacted
legislation to adopt the Pillar Two GLoBE rules, the provisions requiring a 15% minimum effective tax rate on income earned in the respective countries and a global 15%
minimum effective top-up tax are effective for us beginning in our fiscal year ended June 30, 2025. There was no material tax impact to our Condensed Consolidated Financial
Statements from these Pillar Two provisions during the three and nine months ended March 31, 2026.
NOTE 13 – LITIGATION AND OTHER LEGAL MATTERS
We are named, from time to time, as a party to lawsuits and other types of legal proceedings and claims in the normal course of our business. Actions filed against us
include commercial, intellectual property (“IP”), customer, and labor and employment related claims, including complaints of alleged wrongful termination and potential class
action lawsuits regarding alleged violations of federal and state wage and hour and other laws. In general, legal proceedings and claims, regardless of their merit, and associated
internal investigations (especially those relating to IP or confidential information disputes) are often expensive to prosecute, defend or conduct, and may divert management’s
attention and other Company resources. Moreover, the results of legal proceedings are difficult to predict, and the costs incurred in litigation can be substantial, regardless of
outcome. We believe the amounts provided in our Condensed Consolidated Financial Statements are adequate in light of the probable and estimated liabilities. However,
because such matters are subject to many uncertainties and the ultimate outcomes are not predictable, there can be no assurances that the actual amounts required to satisfy
alleged liabilities from the matters described above will not exceed the amounts reflected in our Condensed Consolidated Financial Statements or will not have a material
adverse effect on our results of operations, financial condition or cash flows.
NOTE 14 – COMMITMENTS AND CONTINGENCIES
Factoring. We have factoring agreements with financial institutions to sell certain of our trade receivables and promissory notes from customers without recourse. We do
not believe we are at risk for any material losses as a result of these agreements. In addition, we periodically sell certain letters of credit (“LC”), without recourse, received from
customers in payment for goods and services.
The following table shows total receivables sold under factoring agreements and proceeds from sales of LC for the indicated periods:
Three Months Ended March 31, 	Nine Months Ended March 31,
(In thousands) 	2026 	2025 	2026 	2025
Receivables sold under factoring agreements 	$ 	109,405 $ 	59,734 $ 	286,197 $ 	143,439
Proceeds from sales of LC 	$ 	22,128 $ 	20,188 $ 	43,122 $ 	55,525
Factoring and LC fees for the sale of certain trade receivables were recorded in other expense (income), net and were not material for the periods presented. KLA may
continue servicing the receivables that are sold.
Purchase Commitments. We maintain commitments to purchase inventory from our suppliers as well as goods, services and other assets in the ordinary course of
business. Our liability under these purchase commitments is generally restricted to a forecasted time-horizon as mutually agreed between the parties. This forecasted time-
horizon can vary among different suppliers. Our estimate of our significant purchase commitments primarily for material, services, supplies and asset purchases is
approximately $4.83 billion as of March 31, 2026, a majority of which are due within the next 12 months. Actual expenditures will vary based upon the volume of the
transactions and length of contractual service provided. In addition, the amounts paid under these arrangements may be less in the event that the arrangements are renegotiated
or canceled. Certain agreements provide for potential cancellation penalties.
Cash LTI Plan. As of March 31, 2026, we have committed $114.6 million for future payment obligations under our Cash LTI Plan. Cash LTI awards issued to employees
under the Cash LTI Plan vest in three or four equal installments, with one-third or one-fourth of the aggregate amount of the Cash LTI award vesting on each anniversary of the
grant date over a three- or four-year period. In order to receive payments under a Cash LTI award, participants must remain employed by us as of the applicable award vesting
date.
Guarantees, Contingencies and Other. We maintain guarantee arrangements available through various financial institutions for up to $156.5 million, of which $124.6
million had been issued as of March 31, 2026, primarily to fund

-- 24 of 62 --

Table of Contents
guarantees to customs authorities for value-added tax and other operating requirements of our consolidated subsidiaries worldwide.
We have a duty drawback program that allows for the recovery of certain import duties upon the export of qualifying goods. Our accounting policy is to recognize a
receivable for duty drawback upon submission of a qualifying claim to U.S. Customs and Border Protection when recovery is considered probable and estimable.
In February 2026, the U.S. Supreme Court held that certain tariffs imposed under the International Emergency Economic Powers Act were not authorized. As a result, we
are evaluating the appropriate method and timing of potential recovery of duties previously paid. While the administrative process for obtaining refunds under this ruling has
been outlined, the timing and the potential for legal challenges remains uncertain. Any changes in the administrative process or regulations arising from legal challenges could
impact our results of operations and cash flows, though the effect is not expected to be material.
In January 2025, we entered into a long-term virtual power purchase agreement to purchase a portion of the output generated from a solar energy project for a fixed price.
As part of this agreement, we will also receive renewable energy credits commensurate with the power we acquire. These credits can be applied against our greenhouse gas
emissions, accelerating the progress towards our goals of 100% renewable electricity across our global operations by 2030, reduction of our Scope 1 and 2 emissions from our
2021 baseline by 50% by 2030 and achievement of net zero Scope 1 and Scope 2 emissions by 2050. This agreement had no material impact on our results of operations,
financial condition or cash flows during the three and nine months ended March 31, 2026 or during the three months ended March 31, 2025.
Indemnification Obligations. Subject to certain limitations, we are obligated to indemnify our current and former directors, officers and employees with respect to
certain litigation matters and investigations that arise in connection with their service to us. These obligations arise under the terms of our certificate of incorporation, bylaws,
applicable contracts, and Delaware and California law. The obligation to indemnify generally means that we are required to pay or reimburse the individuals’ reasonable legal
expenses and possibly damages and other liabilities incurred by several of our current and former directors, officers and employees in connection with these matters. For
example, we have paid or reimbursed legal expenses incurred in connection with the investigation of our historical stock option practices and the related litigation and
government inquiries. Although the maximum potential amount of future payments we could be required to make under the indemnification obligations generally described in
this paragraph is theoretically unlimited, we believe the fair value of this liability, to the extent estimable, is appropriately considered within the reserve we have established for
currently pending legal proceedings.
We are a party to a variety of agreements pursuant to which we may be obligated to indemnify the other party with respect to certain matters. Typically, these obligations
arise in connection with contracts and license agreements or the sale of assets, under which we customarily agree to hold the other party harmless against losses arising
therefrom, or provide customers with other remedies to protect against bodily injury or damage to personal property caused by our products, non-compliance with our product
performance specifications, infringement by our products of third-party IP rights and a breach of warranties, representations and covenants related to matters such as title to
assets sold, validity of certain IP rights, non-infringement of third-party rights, and certain income tax-related matters. In each of these circumstances, payment by us is
typically subject to the other party making a claim to and cooperating with us pursuant to the procedures specified in the particular contract. This usually allows us to challenge
the other party’s claims or, in case of breach of IP representations or covenants, to control the defense or settlement of any third-party claims brought against the other party.
Further, our obligations under these agreements may be limited in terms of amounts, activity (typically at our option to replace or correct the products or terminate the
agreement with a refund to the other party), and duration. In some instances, we may have recourse against third parties and/or insurance covering certain payments made by
us.
In addition, we may, in limited circumstances, enter into agreements that contain customer-specific commitments on pricing, tool reliability, spare parts stocking levels,
response time and other commitments. Furthermore, we may give these customers limited audit or inspection rights to enable them to confirm that we are complying with these
commitments. If a customer elects to exercise its audit or inspection rights, we may be required to expend significant resources to support the audit or inspection, as well as to
defend or settle any dispute with a customer that could potentially arise out of such audit or inspection. To date, we have made no significant accruals in our Condensed
Consolidated Financial Statements for this contingency. While we have not in the past incurred significant expenses for resolving disputes regarding these types of
commitments, we cannot make any assurance that we will not incur any such liabilities in the future.
It is not possible to predict the maximum potential amount of future payments under these or similar agreements due to the conditional nature of our obligations and the
unique facts and circumstances involved in each particular agreement. Historically, payments made by us under these agreements have not had a material effect on our business,
financial condition, results of operations or cash flows.

-- 25 of 62 --

Table of Contents
NOTE 15 – DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES
The authoritative guidance requires companies to recognize all derivative instruments, including foreign exchange contracts and rate lock agreements (collectively,
“derivatives”), as either assets or liabilities at fair value on the Condensed Consolidated Balance Sheets. In accordance with the accounting guidance, we designate foreign
currency forward transactions and options contracts and interest rate forward transactions as cash flow hedges. In accordance with the accounting guidance, we also designate
certain foreign currency exchange contracts as net investment hedge transactions intended to mitigate the variability of the value of certain investments in foreign subsidiaries.
Our foreign subsidiaries operate and sell our products in various global markets. As a result, we are exposed to risks relating to changes in foreign currency exchange
rates. We utilize foreign exchange contracts to hedge against future movements in foreign currency exchange rates that affect certain existing and forecasted foreign currency
denominated sales and purchase transactions, such as the Japanese yen, the euro, the pound sterling and the new Israeli shekel.
We routinely hedge our exposures to certain foreign currencies with various financial institutions in an effort to minimize the impact of certain currency exchange rate
fluctuations. These foreign exchange contracts, designated as cash flow hedges, generally have maturities of less than 12 months. Cash flow hedges are evaluated for
effectiveness monthly, based on changes in total fair value of the derivatives. If a financial counterparty to any of our hedging arrangements experiences financial difficulties or
is otherwise unable to honor the terms of the foreign currency hedge, we may experience material losses.
Since fiscal 2015, we have entered into five sets of forward contracts, generally to hedge the benchmark interest rate on portions of our Senior Notes prior to issuance
(collectively, “Rate Lock Agreements”). Upon issuance of the associated debt, the Rate Lock Agreements were settled and their fair values were recorded within AOCI. The
resulting gains and losses from these transactions are amortized to interest expense over the lives of the associated debt. As of March 31, 2026, the aggregate unamortized
portion of the fair value of the forward contracts for the Rate Lock Agreements was a $42.2 million net gain.
For derivatives that are designated and qualify as cash flow hedges, the effective portion of the gains or losses is reported in AOCI and reclassified into earnings in the
same period or periods during which the hedged transaction affects earnings. For derivative contracts executed after adopting the new accounting guidance in fiscal 2019, the
election to include time value for the assessment of effectiveness is made on all forward contracts designated as cash flow hedges. The change in fair value of the derivative is
recorded in AOCI until the hedged item is recognized in earnings. The assessment of effectiveness of options contracts designated as cash flow hedges exclude time value. The
initial value of the component excluded from the assessment of effectiveness is recognized in earnings over the life of the derivative contract. Any differences between changes
in the fair value of the excluded components and the amounts recognized in earnings are recorded in AOCI.
For derivatives that are designated and qualify as a net investment hedge in a foreign operation and that meet the effectiveness requirements, the net gains or losses
attributable to changes in spot exchange rates are recorded in cumulative translation within AOCI. The remainder of the change in value of such instruments is recorded in
earnings on a straight-line basis over the lives of the associated derivative contracts. Recognition in earnings of amounts previously recorded in cumulative translation is limited
to circumstances such as complete or substantially complete liquidation or sale of the net investment in the hedged foreign operations.
For derivatives that are not designated as hedges, gains and losses are recognized in Other expense (income), net. We use foreign exchange contracts to hedge certain
foreign currency denominated assets or liabilities. The gains and losses on these derivative instruments are largely offset by the changes in the fair value of the assets or
liabilities being hedged.

-- 26 of 62 --

Table of Contents
Derivatives in Hedging Relationships: Foreign Exchange Contracts and Rate Lock Agreements
The gains (losses) on derivatives in cash flow and net investment hedging relationships recognized in other comprehensive income for the indicated periods were as
follows:
Three Months Ended March 31, 	Nine Months Ended March 31,
(In thousands) 	2026 	2025 	2026 	2025
Derivatives Designated as Cash Flow Hedging Instruments:
Foreign exchange contracts:
Amounts included in the assessment of effectiveness 	$ 	(288) $ 	(1,893) $ 	15,406 $ 	3,254
Amounts excluded from the assessment of effectiveness 	$ 	18 $ 	42 $ 	93 $ 	(118)
Derivatives Designated as Net Investment Hedging Instruments:
Foreign exchange contracts : 	$ 	193 $ 	1,730 $ 	25,775 $ 	3,443
__________________
(1) 	No amounts were reclassified from AOCI into earnings related to the sale of a subsidiary, as there were no such sales during the periods presented.
The locations and amounts of designated and non-designated derivatives’ gains and losses reported in the Condensed Consolidated Statements of Operations for the
indicated periods were as follows:
Three Months Ended March 31, 	Three Months Ended March 31,
2026 	2025
(In thousands) 	Revenues
Costs of Revenues
and Operating
Expenses 	Interest Expense
Other Expense
(Income), Net 	Revenues
Costs of
Revenues and
Operating
Expenses 	Interest Expense
Other Expense
(Income), Net
Total amounts presented in the Condensed
Consolidated Statements of Operations in
which the effects of cash flow hedges are
recorded 	$ 	3,415,078 $ 	2,007,569 $ 	70,423 $ 	(79,675) $ 	3,063,029 $ 	1,762,637 $ 	71,889 $ 	(35,930)
Gains (Losses) on Derivatives Designated as Hedging Instruments:
Rate lock agreements:
Amount of gains reclassified from AOCI to
earnings 	$ 	— $ 	— $ 	758 $ 	— $ 	— $ 	— $ 	758 $ 	—
Foreign exchange contracts:
Amount of gains (losses) reclassified from
AOCI to earnings 	$ 	2,293 $ 	11,436 $ 	— $ 	— $ 	3,006 $ 	(2,146) $ 	— $ 	—
Amount excluded from the assessment of
effectiveness recognized in earnings 	$ 	(222) $ 	— $ 	— $ 	6,806 $ 	(326) $ 	— $ 	— $ 	363
Gains (Losses) on Derivatives Not Designated as Hedging Instruments:
Amount of gains (losses) recognized in
earnings 	$ 	— $ 	— $ 	— $ 	1 $ 	— $ 	— $ 	— $ 	(7,790)
(1)

-- 27 of 62 --

Table of Contents
Nine Months Ended March 31, 	Nine Months Ended March 31,
2026 	2025
(In thousands) 	Revenues
Costs of Revenues
and Operating
Expenses 	Interest Expense
Other Expense
(Income), Net 	Revenues
Costs of
Revenues and
Operating
Expenses 	Interest Expense
Other Expense
(Income), Net
Total amounts presented in the Condensed
Consolidated Statements of Operations in
which the effects of cash flow hedges are
recorded 	$ 	9,921,920 $ 	5,815,088 $ 	211,166 $ 	(160,874) $ 	8,981,421 $ 	5,558,054 $ 	229,041 $ 	(121,323)
Gains (Losses) on Derivatives Designated as Hedging Instruments:
Rate lock agreements:
Amount of gains reclassified from AOCI to
earnings 	$ 	— $ 	— $ 	2,275 $ 	— $ 	— $ 	— $ 	2,526 $ 	—
Foreign exchange contracts:
Amount of gains (losses) reclassified from
AOCI to earnings 	$ 	5,112 $ 	31,896 $ 	— $ 	— $ 	7,435 $ 	(1,692) $ 	— $ 	—
Amount excluded from the assessment of
effectiveness recognized in earnings 	$ 	(638) $ 	— $ 	— $ 	16,345 $ 	(1,209) $ 	— $ 	— $ 	6,336
Gains (Losses) on Derivatives Not Designated as Hedging Instruments:
Amount of gains (losses) recognized in
earnings 	$ 	— $ 	— $ 	— $ 	13,099 $ 	— $ 	— $ 	— $ 	(4,390)
The U.S. dollar equivalent of all outstanding notional amounts of foreign currency hedge contracts and rate lock agreements, with maximum remaining maturities of
approximately 12 months as of the dates indicated below, were as follows:
As of 	As of
(In thousands) 	March 31, 2026 	June 30, 2025
Cash flow hedge contracts - foreign currency
Purchase 	$ 	505,004 $ 	405,349
Sell 	$ 	88,114 $ 	159,475
Net investment hedge contracts - foreign currency
Sell 	$ 	390,677 $ 	384,130
Other foreign currency hedge contracts
Purchase 	$ 	647,088 $ 	618,844
Sell 	$ 	572,240 $ 	429,643
The locations and fair value of our derivatives reported in our Condensed Consolidated Balance Sheets as of the dates indicated below were as follows:
Asset Derivatives 	Liability Derivatives
Balance Sheet 	As of 	As of 	Balance Sheet 	As of 	As of
Location 	March 31, 2026 	June 30, 2025 	Location 	March 31, 2026 	June 30, 2025
(In thousands) 	Fair Value 	Fair Value
Derivatives designated as hedging instruments
Foreign exchange contracts 	Other current assets 	$ 	33,949 $ 	29,492 Other current
liabilities 	$ 	(8,831) $ 	(24,331)
Total derivatives designated as hedging
instruments 	33,949 	29,492 	(8,831) 	(24,331)
Derivatives not designated as hedging
instruments
Foreign exchange contracts 	Other current assets 	10,271 	30,011 Other current
liabilities 	(10,563) 	(4,284)
Total derivatives not designated as hedging
instruments 	10,271 	30,011 	(10,563) 	(4,284)
Total derivatives 	$ 	44,220 $ 	59,503 	$ 	(19,394) $ 	(28,615)

-- 28 of 62 --

Table of Contents
The changes in AOCI, before taxes, related to derivatives for the indicated periods were as follows:
Three Months Ended March 31, 	Nine Months Ended March 31,
(In thousands) 	2026 	2025 	2026 	2025
Beginning AOCI 	$ 	83,541 $ 	69,835 	$ 	66,570 $ 	68,903
Amount reclassified to earnings as net gains 	(14,265) 	(1,292) 	(38,645) 	(7,060)
Net change in unrealized gains (losses) 	(77) 	(121) 	41,274 	6,579
Ending AOCI 	$ 	69,199 $ 	68,422 	$ 	69,199 $ 	68,422
As of March 31, 2026, the net gain reported in AOCI that is expected to be reclassified into earnings within the next 12 months is $14.3 million.
Offsetting of Derivative Assets and Liabilities
We present derivatives at gross fair values in the Condensed Consolidated Balance Sheets. We have entered into arrangements with each of our counterparties, which
reduce credit risk by permitting net settlement of transactions with the same counterparty under certain conditions. The information related to the offsetting arrangements for
the periods indicated was as follows:
As of March 31, 2026
Gross Amounts of Derivatives Not Offset in
the Condensed Consolidated Balance Sheets
(In thousands)
Gross Amounts of
Derivatives
Gross Amounts of Derivatives
Offset in the Condensed
Consolidated Balance Sheets
Net Amount of Derivatives
Presented in the Condensed
Consolidated Balance Sheets 	Financial Instruments
Cash Collateral
Received 	Net Amount
Derivatives - assets 	$ 	44,220 $ 	— $ 	44,220 $ 	(17,298) $ 	— $ 	26,922
Derivatives - liabilities 	$ 	(19,394) $ 	— $ 	(19,394) $ 	17,298 $ 	— $ 	(2,096)
As of June 30, 2025
Gross Amounts of Derivatives Not Offset in
the Condensed Consolidated Balance Sheets
(In thousands)
Gross Amounts of
Derivatives
Gross Amounts of Derivatives
Offset in the Condensed
Consolidated Balance Sheets
Net Amount of Derivatives
Presented in the Condensed
Consolidated Balance Sheets 	Financial Instruments Cash Collateral
Received 	Net Amount
Derivatives - assets 	$ 	59,503 $ 	— $ 	59,503 $ 	(28,615) $ 	— $ 	30,888
Derivatives - liabilities 	$ 	(28,615) $ 	— $ 	(28,615) $ 	28,615 $ 	— $ 	—
NOTE 16 – SEGMENT REPORTING AND GEOGRAPHIC INFORMATION
ASC 280, Segment Reporting, establishes standards for reporting information about operating segments. Operating segments are defined as components of an enterprise
about which separate financial information is evaluated regularly by the chief operating decision maker (“CODM”) in deciding how to allocate resources and in assessing
performance. Our CODM is our Chief Executive Officer.
Our operating segments are aggregated into reportable segments based on several factors including, but not limited to, customer base, homogeneity of products,
technology, delivery channels and similar economic characteristics. We have three reportable segments: Semiconductor Process Control; Specialty Semiconductor Process; and
PCB and Component Inspection.
Semiconductor Process Control
The Semiconductor Process Control segment offers a comprehensive portfolio of inspection, metrology and data analytics products, and related services, which helps
integrated circuit (“IC”) manufacturers achieve target yield throughout the entire semiconductor fabrication process, from R&D to final volume production. Our differentiated
products and services are designed to provide comprehensive solutions that help our customers accelerate development and production ramp cycles, achieve higher and more
stable semiconductor die yields and improve their overall profitability.

-- 29 of 62 --

Table of Contents
Specialty Semiconductor Process
The Specialty Semiconductor Process segment develops and sells advanced vacuum deposition and etching process tools, which are used by a broad range of specialty
semiconductor customers, including manufacturers of microelectromechanical systems (“MEMS”), radio frequency (“RF”) communication chips and power semiconductors for
automotive and industrial applications.
PCB and Component Inspection
The PCB and Component Inspection segment enables electronic device manufacturers to inspect, test and measure PCBs, flat panel displays and ICs to verify their
quality, pattern the desired electronic circuitry on the relevant substrate and perform three-dimensional shaping of metalized circuits on multiple surfaces. In March 2024, we
made the decision to exit the Display business by announcing we would end manufacturing of most Display products but will continue to provide services to the installed base
of Display products for existing customers.
The CODM uses total segment revenues and segment profit (loss) to assess performance and allocate resources (including employees, financial or capital resources),
primarily during the annual strategic long-term planning and budgeting process. The CODM considers changes in market conditions, technology constraints and the
competitive environment when making decisions about allocating resources to segments. The CODM does not evaluate segments using discrete asset information because asset
allocation is not managed at the segment level and assets are not tracked by segment in a way that it is meaningful for decision-making. Segment profit (loss) represents
segment income (loss) before income taxes, and excludes interest expense, other expense (income), net, restructuring costs, effects of changes in foreign currency exchange
rates, and other corporate expenses.

-- 30 of 62 --

Table of Contents
The following is a summary of results for each of our three reportable segments for the indicated periods:
(In thousands)
Semiconductor Process
Control Specialty Semiconductor
Process PCB and Component
Inspection 	Total
For the three months ended March 31, 2026
Revenue 	$ 	3,083,912 $ 	164,028 $ 	167,642 $ 	3,415,582
Less:
Cost of revenue 	1,127,180 	88,505 	80,956
R&D 	344,303 	13,806 	29,905
SG&A 	240,772 	11,524 	24,033
Other segment items 	8,805 	26,754 	11,420
Segment profit 	$ 	1,362,852 $ 	23,439 $ 	21,328 $ 	1,407,619
For the three months ended March 31, 2025
Revenue 	$ 	2,738,817 $ 	156,500 $ 	168,552 $ 	3,063,869
Less:
Cost of revenue 	973,623 	72,673 	87,453
R&D 	289,222 	12,827 	30,414
SG&A 	198,305 	10,415 	23,909
Other segment items 	10,062 	27,199 	16,402
Segment profit 	$ 	1,267,605 $ 	33,386 $ 	10,374 $ 	1,311,365
For the nine months ended March 31, 2026
Revenue 	$ 	8,987,952 $ 	424,360 $ 	509,305 $ 	9,921,617
Less:
Cost of revenue 	3,269,059 	223,734 	254,571
R&D 	989,147 	44,223 	99,018
SG&A 	693,436 	34,912 	75,002
Other segment items 	28,294 	81,316 	35,397
Segment profit 	$ 	4,008,016 $ 	40,175 $ 	45,317 $ 	4,093,508
For the nine months ended March 31, 2025
Revenue 	$ 	8,069,711 $ 	445,241 $ 	467,615 $ 	8,982,567
Less:
Cost of revenue 	2,924,658 	215,798 	273,453
R&D 	862,992 	34,145 	101,750
SG&A 	607,133 	38,117 	77,962
Other segment items 	32,185 	81,763 	294,166
Segment profit (loss) 	$ 	3,642,743 $ 	75,418 $ 	(279,716) $ 	3,438,445
__________________
(1) 	Other segment items for each reportable segment includes:
• 	Semiconductor Process Control — amortization of purchased intangible assets and acquisition related expenses.
• 	Specialty Semiconductor Process — amortization of purchased intangible assets.
• 	PCB and Component Inspection — amortization of purchased intangible assets for all periods presented and impairment of goodwill and purchased intangible
assets for the nine months ended March 31, 2025.
(1)
(1)
(1)
(1)

-- 31 of 62 --

Table of Contents
The following table reconciles total reportable segment revenue to total revenue for the indicated periods:
Three Months Ended March 31, 	Nine Months Ended March 31,
(In thousands) 	2026 	2025 	2026 	2025
Total revenues for reportable segments 	$ 	3,415,582 $ 	3,063,869 $ 	9,921,617 $ 	8,982,567
Effects of changes in foreign currency exchange rates 	(504) 	(840) 	303 	(1,146)
Total revenues 	$ 	3,415,078 $ 	3,063,029 $ 	9,921,920 $ 	8,981,421
The following table reconciles total segment profit to total income before income taxes for the indicated periods:
Three Months Ended March 31, 	Nine Months Ended March 31,
(In thousands) 	2026 	2025 	2026 	2025
Total segment profit 	$ 	1,407,619 $ 	1,311,365 $ 	4,093,508 $ 	3,438,445
Unallocated amounts 	110 	10,973 	(13,324) 	15,078
Interest expense 	70,423 	71,889 	211,166 	229,041
Other expense (income), net 	(79,675) 	(35,930) 	(160,874) 	(121,323)
Income before income taxes 	$ 	1,416,761 $ 	1,264,433 $ 	4,056,540 $ 	3,315,649
__________________
(1) 	Unallocated amounts include effects of changes in exchange rates, restructuring costs and other corporate expenses.
Our significant operations outside the United States include manufacturing facilities in China, Germany, Israel and Singapore and sales, marketing and service offices in
Japan, the rest of the Asia Pacific region and Europe. For geographical revenue reporting, revenues are attributed to the geographic location in which the customer is located.
Long-lived assets consist of land, property and equipment, net, and are attributed to the geographic region in which they are located.
The following is a summary of revenues by geographic region, based on ship-to location, for the indicated periods:
(Dollar amounts in thousands)
Three Months Ended March 31, 	Nine Months Ended March 31,
2026 	2025 	2026 	2025
Revenues:
Taiwan 	$ 	869,110 	25.5 % $ 	988,470 	32.3 % $ 	2,507,705 	25.3 % $ 	2,331,672 	26.0 %
China 	829,583 	24.3 % 	792,884 	25.9 % 	3,091,630 	31.2 % 	3,083,713 	34.3 %
Korea 	681,060 	19.9 % 	378,548 	12.4 % 	1,459,747 	14.7 % 	974,656 	10.9 %
North America 	410,241 	12.0 % 	293,980 	9.6 % 	1,102,379 	11.1 % 	1,081,114 	12.0 %
Europe and Israel 	247,323 	7.2 % 	170,056 	5.5 % 	559,469 	5.6 % 	449,142 	5.0 %
Rest of Asia 	197,387 	5.8 % 	100,440 	3.3 % 	496,357 	5.0 % 	305,290 	3.4 %
Japan 	180,374 	5.3 % 	338,651 	11.0 % 	704,633 	7.1 % 	755,834 	8.4 %
Total 	$ 	3,415,078 	100.0 % $ 	3,063,029 	100.0 % $ 	9,921,920 	100.0 % $ 	8,981,421 	100.0 %
The following is a summary of revenues by major product categories for the indicated periods:
(Dollar amounts in thousands)
Three Months Ended March 31, 	Nine Months Ended March 31,
2026 	2025 	2026 	2025
Revenues:
Wafer Inspection 	$ 	1,739,671 	51 % $ 	1,495,685 	49 % $ 	4,849,697 	49 % $ 	4,427,238 	49 %
Patterning 	615,076 	18 % 	636,415 	21 % 	1,978,664 	20 % 	1,743,504 	20 %
Specialty Semiconductor Process 	144,199 	4 % 	138,376 	4 % 	366,006 	4 % 	394,165 	4 %
PCB and Component Inspection 	95,148 	3 % 	104,254 	3 % 	292,794 	3 % 	270,489 	3 %
Services 	774,791 	23 % 	669,208 	22 % 	2,305,534 	23 % 	1,980,749 	22 %
Other 	46,193 	1 % 	19,091 	1 % 	129,225 	1 % 	165,276 	2 %
Total 	$ 	3,415,078 	100 % $ 	3,063,029 	100 % $ 	9,921,920 	100 % $ 	8,981,421 	100 %
(1)

-- 32 of 62 --

Table of Contents
Wafer Inspection and Patterning products are offered in the Semiconductor Process Control segment. Services are offered in multiple segments. Other includes primarily
refurbished systems, remanufactured legacy systems, and enhancements and upgrades for previous-generation products that are part of the Semiconductor Process Control
segment.
In the three months ended March 31, 2026, two customers accounted for approximately 19% and 11% of total revenues each. In the three months ended March 31, 2025,
one customer accounted for approximately 23% of total revenues. In the nine months ended March 31, 2026, one customer accounted for approximately 17% of total revenues.
In the nine months ended March 31, 2025, one customer accounted for approximately 20% of total revenues. Three customers and two customers on an individual basis
accounted for greater than 10% of accounts receivable, net, at March 31, 2026 and June 30, 2025, respectively.
Land, property and equipment, net by geographic region as of the dates indicated below were as follows:
As of 	As of
(In thousands) 	March 31, 2026 	June 30, 2025
Land, property and equipment, net:
United States 	$ 	768,968 $ 	728,162
Europe 	285,242 	253,848
Singapore 	178,574 	153,052
Rest of Asia 	71,784 	49,109
Israel 	59,216 	68,604
Total 	$ 	1,363,784 $ 	1,252,775
NOTE 17 – RESTRUCTURING CHARGES
From time to time, management approves restructuring plans including workforce reductions in an effort to streamline operations.
Restructuring charges were $0.2 million and $0.6 million for the three months ended March 31, 2026 and 2025, respectively. Restructuring charges were $0.9 million and
$5.6 million for the nine months ended March 31, 2026 and 2025, respectively. The charges for fiscal years 2026 and 2025 include severance and related charges for the
restructuring of the former PCB and Display operating segment, as a result of exiting the Display business. As of March 31, 2026 and June 30, 2025, the accrual for
restructuring charges was $4.9 million and $5.9 million, respectively.

-- 33 of 62 --

Table of Contents
ITEM 2. MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS
SPECIAL NOTE REGARDING FORWARD-LOOKING STATEMENTS
This report contains certain forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act
of 1934, as amended (the “Securities Exchange Act”). All statements other than statements of historical fact may be forward-looking statements. You can identify these and
other forward-looking statements by the use of words such as “may,” “will,” “could,” “would,” “should,” “expects,” “plans,” “anticipates,” “relies,” “believes,”
“estimates,” “predicts,” “intends,” “potential,” “continues,” “thinks,” “seeks,” “commits”, or the negative of such terms, or other comparable terminology. Forward-
looking statements also include the assumptions underlying or relating to any of the foregoing statements. Such forward-looking statements include those regarding, among
others: the impact of tariffs on our business; forecasts of the future results of our operations, including profitability; orders for our products and capital equipment generally;
sales of semiconductors; the investments by our customers in advanced technologies and new materials; growth of revenue in the semiconductor industry, the semiconductor
capital equipment industry and our business; technological trends in the semiconductor industry; future developments or trends in the global capital and financial markets; our
future product offerings and product features; the success and market acceptance of new products; timing of shipment of order backlog; our future product shipments and
product and service revenues; our future gross margins; our future research and development (“R&D”) expenses and selling, general and administrative (“SG&A”) expenses;
international sales and operations; our ability to maintain or improve our existing competitive position; success of our product offerings; creation and funding of programs for
R&D; results of our investment in leading edge technologies; the effects of hedging transactions; the effect of the sale of trade receivables and promissory notes from
customers; the effect of future compliance with laws and regulations; our future effective income tax rate; our recognition of tax benefits; the effects of any audits or litigation;
future payments of dividends to our stockholders; the completion of any acquisitions of third parties, or the technology or assets thereof; benefits received from any acquisitions
and development of acquired technologies; sufficiency of our existing cash balance, investments, cash generated from operations and the unfunded portion of our Revolving
Credit Facility (as defined below in the “Revolving Credit Facility” section of “Liquidity and Capital Resources”) to meet our operating and working capital requirements,
including debt service and payment thereof; future dividends, and stock repurchases; our compliance with the financial covenants under the Credit Agreement (as defined
below in the “Revolving Credit Facility” section of “Liquidity and Capital Resources”) for our Revolving Credit Facility; the adoption of new accounting pronouncements; our
repayment of our outstanding indebtedness; and our environmental, social and governance (“ESG”) related targets, goals and commitments.
Our actual results may differ significantly from those projected in the forward-looking statements in this report. Factors that might cause or contribute to such differences
include, but are not limited to:
• 	Our vulnerability to a weakening in the condition of the financial markets and the global economy;
• 	Risks related to our international operations;
• 	Evolving Bureau of Industry and Security (“BIS”) of the U.S. Department of Commerce (“Commerce”) rules and regulations (the “BIS Rules”) and their impact on
our ability to sell products to and provide services to certain customers in People’s Republic of China (“China”);
• 	Tariffs and other trade restrictions;
• 	Costly intellectual property (“IP”) disputes that could result in our inability to sell or use the challenged technology;
• 	Risks related to the legal, regulatory and tax environments in which we conduct our business;
• 	Differing stakeholder expectations, requirements and attention to ESG matters and the resulting costs, risks and impact on our business;
• 	Unexpected delays, difficulties and expenses in executing against our environmental, climate, or other ESG targets, goals and commitments;
• 	Our ability to attract, retain and motivate key personnel;
• 	Our vulnerability to disruptions and delays at our third-party service providers;
• 	Cybersecurity threats, cyber incidents affecting our and our business partners’ systems and networks;
• 	Our inability to access critical information in a timely manner due to system failures;
• 	Risks related to acquisitions, integrations, strategic alliances or collaborative arrangements;

-- 34 of 62 --

Table of Contents
• 	Climate change, earthquake, flood or other natural catastrophic events, public health crises or terrorism and the adverse impact on our business operations;
• 	The war between Ukraine and Russia, the armed conflict in Iran and elsewhere in the Middle East, and the significant military activity in those regions;
• 	Lack of insurance for losses and interruptions caused by terrorists and acts of war, and our self-insurance of certain risks including earthquake risk;
• 	Risks related to fluctuations in foreign currency exchange rates;
• 	Risks related to fluctuations in interest rates and the market values of our portfolio investments;
• 	Risks related to tax and regulatory compliance audits;
• 	Any change in taxation rules or practices and our effective tax rate;
• 	Compliance costs with federal securities laws, rules, regulations, NASDAQ requirements, and evolving accounting standards and practices;
• 	Ongoing changes in the technology industry, and the semiconductor industry in particular, including future growth rates, pricing trends in end-markets, or changes in
customer capital spending patterns;
• 	Our vulnerability to a highly concentrated customer base;
• 	The cyclicality of the industries in which we operate;
• 	Our ability to timely develop new technologies and products that successfully address changes in the industry;
• 	Risks related to artificial intelligence (“AI”);
• 	Our ability to maintain our technology advantage and protect proprietary rights;
• 	Our ability to compete in the industry;
• 	Availability and cost of the materials and parts used in the production of our products;
• 	Our ability to operate our business in accordance with our business plan;
• 	Risks related to our debt and leveraged capital structure;
• 	We may not be able to declare cash dividends at all or in any particular amount;
• 	Liability to our customers under indemnification provisions if our products fail to operate properly or contain defects or our customers are sued by third parties due to
our products;
• 	Our government funding for R&D is subject to audit, and potential termination or penalties;
• 	We may incur significant restructuring charges or other asset impairment charges or inventory write offs;
• 	We are subject to risks related to receivables factoring arrangements and compliance risk of certain settlement agreements with the government; and
• 	Risks related to the Court of Chancery of the State of Delaware being the sole and exclusive forum for certain actions and proceedings.
For a more detailed discussion of these and other risk factors that might cause or contribute to differences from the forward-looking statements in this report, see Part II,
Item 1A “Risk Factors” in this report as well as Part I, Item 1 “Business”, Part I, Item 1A “Risk Factors” and Part II, Item 7 “Management’s Discussion and Analysis of
Financial Condition and Results of Operations” in our Annual Report on Form 10-K for the year ended June 30, 2025. You should carefully review these risks and also review
the risks described in documents we file from time to time with the Securities and Exchange Commission. You are cautioned not to place undue reliance on these forward-
looking statements, and we expressly assume no obligation and do not intend to update the forward-looking statements in this report after the date hereof.
EXECUTIVE SUMMARY
We are a leading supplier of process control and yield management solutions and services for the semiconductor and related electronics industries. Our broad portfolio of
inspection and metrology products, and related service, software and other offerings, support R&D and manufacturing of integrated circuits (“IC”), wafers and reticles. Our
products, services and expertise are used by our customers to measure, detect, analyze and resolve critical and nanometric level product defects, helping them to manage
manufacturing process challenges and to obtain higher finished product yields at lower cost. We also offer advanced technology solutions to address various manufacturing
needs of printed circuit boards (“PCB”), specialty semiconductor devices and other electronic components, including advanced packaging, light-emitting diode (“LED”), power
devices, compound semiconductor, and data storage industries, as well as general materials research. In addition, our services business has grown consistently year-over-year
and accounted for approximately 23% of our total revenues in the third quarter of fiscal 2026. Our services revenue, which is generated largely from recurring “subscription-
like” contracts, increases the value of our contract offerings and extension of system lifetimes resulting from growth in legacy semiconductor markets.

-- 35 of 62 --

Table of Contents
We are organized into three reportable segments as follows:
• 	Semiconductor Process Control: a comprehensive portfolio of inspection, metrology and data analytics products as well as related service offerings that help IC
manufacturers achieve target yields throughout the semiconductor fabrication process, from R&D to final volume production.
• 	Specialty Semiconductor Process: advanced vacuum deposition and etching process tools used by a broad range of specialty semiconductor customers.
• 	PCB and Component Inspection: a range of inspection, testing and measurement, and direct imaging for patterning products used by manufacturers of PCBs, advanced
packaging, microelectromechanical systems (“MEMS”) and other electronic components.
The semiconductor industry continues to experience significant market expansion and diversification. High-performance computing and data centers, fueled by
widespread adoption of AI, are driving industry growth. We expect this momentum to continue during calendar year 2026. AI is a technology inflection point driving innovation
and demand at the leading edge, and we believe our portfolio of products is uniquely positioned to support leading-edge demand and the ongoing AI buildout. Our
semiconductor customers generally operate in one or both of the major semiconductor device manufacturing markets: memory and foundry/logic. End-market demand drivers
that are expected to continue to benefit KLA in the long term include adoption of extreme ultraviolet lithography (“EUV”) in high volume manufacturing for Logic and DRAM
memory (including high-bandwidth memory), which drives new process control requirements and growth in key markets for KLA. Demand for advanced semiconductor
technologies, particularly evident in the 2-nanometer node, which is seeing higher levels of investment and process control intensity, continues to drive investments in AI.
Increasing complexity and value of semiconductor packages, particularly for AI and high-performance computing applications, is also driving significant growth in our
advanced packaging business. The digitization of all industries, including 5G markets, advances in healthcare and industrial applications, together with the increasing adoption
of electric vehicles and intelligence in automobiles, are powering leading-edge design node technology investments and capacity expansions.
While we continue to invest in technological innovation, factors such as delays from customers in adopting new chips and technology methods could impact process
control capital intensity. Pushouts or cancellations of deliveries to our customers could cause earnings volatility, due to the timing of revenue recognition as well as increased
risk of inventory-related charges. Geopolitical factors, such as government regulations and tariffs, have had an adverse impact on our results of operations. However, despite
these headwinds, our total revenues and net income improved in the three months ended March 31, 2026 compared to the three months ended March 31, 2025. Looking ahead,
while we expect continued revenue growth in calendar year 2026, escalating costs for DRAM chips used in the Company’s image computers will continue to negatively impact
our gross margin, though we expect this impact to be transitory.
We are continuously assessing the aggregate potential impact of government regulations, tariffs and other geopolitical risks on our financial results and operations. See
Part II, Item 1A “Risk Factors” below, and also Part I, Item 1A “Risk Factors” in our Annual Report on Form 10-K for our fiscal year ended June 30, 2025 for more information
regarding how such actions by the U.S. government or another country could significantly impact our ability to provide our products and services to existing and potential
customers, especially in China, and adversely affect our business, financial condition and results of operations.
The following table sets forth some of our key quarterly unaudited financial information:
(Dollar amounts in thousands, except net income per share)
Three Months Ended
March 31,
2026 December 31,
2025 September 30,
2025 June 30,
2025 March 31,
2025
Total revenues 	$ 	3,415,078 	$ 	3,297,146 	$ 	3,209,696 	$ 	3,174,741 	$ 	3,063,029
Costs of revenues 	$ 	1,327,672 	$ 	1,271,210 	$ 	1,243,070 	$ 	1,207,286 	$ 	1,175,689
Gross margin 	61.1% 	61.4% 	61.3% 	62.0% 	61.6%
Net income 	$ 	1,200,990 	$ 	1,145,682 	$ 	1,121,040 	$ 	1,202,849 	$ 	1,088,416
Diluted net income per share 	$ 	9.12 	$ 	8.68 	$ 	8.47 	$ 	9.06 	$ 	8.16
__________________
(1) For the explanation why our net income increased to $1.20 billion in the three months ended March 31, 2026 compared to the three months ended March 31, 2025, refer
to the “Results of Operations” section below, as the change is a result of movements in various income statement line items.
(1)
(2)

-- 36 of 62 --

Table of Contents
(2) Diluted net income per share is computed independently for each of the quarters presented based on the weighted-average fully diluted shares outstanding for each
quarter. Therefore, the sum of quarterly diluted net income per share information may not equal annual (or other multiple-quarter calculations of) diluted net income per
share.
We continue to focus on returning cash to our investors, making $626.0 million in share repurchases and paying $248.8 million in dividends in the three months ended
March 31, 2026. Our Board of Directors has authorized a program that permits us to repurchase our common stock, including an increase in the authorized repurchase amount
of $7.00 billion in the third quarter of fiscal 2026. As of March 31, 2026, we had $10.31 billion of repurchase authority remaining. In March 2026, we also announced an
increase in the dividend level to $2.30 per share per quarter, which was our 17th consecutive annual dividend increase. Refer to the “Liquidity and Capital Resources” section
below for more information on our strong cash flow generation and strategy of returning excess cash to our stockholders.
CRITICAL ACCOUNTING ESTIMATES
The preparation of our Condensed Consolidated Financial Statements in conformity with accounting principles generally accepted in the United States of America
requires management to make estimates and assumptions in applying our accounting policies that affect the reported amounts of assets, liabilities, revenues and expenses, and
related disclosure of contingent assets and liabilities. We base these estimates and assumptions on historical experience and evaluate them on an ongoing basis to ensure that
they remain reasonable under current conditions. Actual results could differ from those estimates.
There have been no material changes in our critical accounting estimates since our Annual Report on Form 10-K for the fiscal year ended June 30, 2025. Refer to
“Management’s Discussion and Analysis of Financial Condition and Results of Operations” contained in Part II, Item 7 of our Annual Report on Form 10-K for our fiscal year
ended June 30, 2025 for a complete description of our critical accounting estimates.
Recent Accounting Pronouncements
For a description of recent accounting pronouncements, including those recently adopted and the expected dates of adoption as well as estimated effects, if any, on our
Condensed Consolidated Financial Statements of those not yet adopted, see Note 1 “Basis of Presentation” to our Condensed Consolidated Financial Statements.

-- 37 of 62 --

Table of Contents
RESULTS OF OPERATIONS
Revenues and Gross Margin
Our business is affected by the concentration of our customer base and our customers’ capital equipment procurement schedules as a result of their investment plans. Our
product revenues in any particular period are impacted by the amount of new orders we receive during that period and, depending upon the duration of manufacturing and
installation cycles, in the preceding periods. Revenue is also impacted by average customer pricing, customer revenue deferrals associated with volume purchase agreements,
the effect of fluctuations in foreign currency exchange rates, increased trade restrictions and the availability of government incentives for semiconductor capital investments.
Service revenues are generated from product maintenance and support services, as well as billable time and material service calls made to our customers. The amount of our
service revenues is typically a function of the number of systems installed at our customers’ sites and the utilization of those systems, but it is also impacted by other factors,
such as our rate of service contract renewals, the types of systems being serviced and fluctuations in foreign currency exchange rates. A significant portion of our revenues
continues to be generated in Asia, where a substantial portion of the world’s semiconductor manufacturing capacity is located, and we expect that trend to continue.
Three Months Ended March 31, 	Q3 FY26
vs.
Q3 FY25	(Dollar amounts in thousands) 	2026 	2025
Revenues:
Product 	$ 	2,640,287 	$ 	2,393,821 	$ 	246,466 	10 %
Service 	774,791 	669,208 	105,583 	16 %
Total revenues 	$ 	3,415,078 	$ 	3,063,029 	$ 	352,049 	11 %
Costs of revenues 	$ 	1,327,672 	$ 	1,175,689 	$ 	151,983 	13 %
Gross margin 	61.1% 	61.6%
Nine Months Ended March 31, 	Q3 FY26 YTD
vs.
Q3 FY25 YTD	(Dollar amounts in thousands) 	2026 	2025
Revenues:
Product 	$ 	7,616,386 	$ 	7,000,672 	$ 	615,714 	9 %
Service 	2,305,534 	1,980,749 	324,785 	16 %
Total revenues 	$ 	9,921,920 	$ 	8,981,421 	$ 	940,499 	10 %
Costs of revenues 	$ 	3,841,952 	$ 	3,544,581 	$ 	297,371 	8 %
Gross margin 	61.3 % 	60.5 %
Total revenues increased 11% in the three months ended March 31, 2026 compared to the three months ended March 31, 2025, primarily due to the increase in product
revenues, and is attributable to higher investments from our memory customers, particularly in DRAM, led by high-bandwidth memory, and steady growth in foundry/logic. An
increase in service revenues of 16%, due to continued growth in our installed base of tools, also contributed to higher total revenues compared to the same period in the prior
year.
Total revenues increased 10% in the nine months ended March 31, 2026 compared to the nine months ended March 31, 2025, primarily due to the increase in our product
revenues, and is attributable to higher investments by our memory customers, particularly in DRAM, led by high-bandwidth memory, strong customer adoption of our
advanced packaging portfolio of products, and steady growth in foundry/logic. An increase in service revenues of 16%, as a result of continued growth of our installed base of
tools, also contributed to higher total revenues compared to the same period in the prior year.

-- 38 of 62 --

Table of Contents
Revenues by segment
Three Months Ended March 31, 	Q3 FY26
vs.
Q3 FY25	(Dollar amounts in thousands) 	2026 	2025
Revenues:
Semiconductor Process Control 	$ 	3,083,912 $ 	2,738,817 $ 	345,095 	13 %
Specialty Semiconductor Process 	164,028 	156,500 	7,528 	5 %
PCB and Component Inspection 	167,642 	168,552 	(910) 	(1)%
Total revenues for reportable segments 	$ 	3,415,582 $ 	3,063,869 $ 	351,713 	11 %
Nine Months Ended March 31, 	Q3 FY26 YTD
vs.
Q3 FY25 YTD	(Dollar amounts in thousands) 	2026 	2025
Revenues:
Semiconductor Process Control 	$ 	8,987,952 $ 	8,069,711 $ 	918,241 	11 %
Specialty Semiconductor Process 	424,360 	445,241 	(20,881) 	(5)%
PCB and Component Inspection 	509,305 	467,615 	41,690 	9 %
Total revenues for reportable segments 	$ 	9,921,617 $ 	8,982,567 $ 	939,050 	10 %
_______________
(1) 	Segment revenues exclude corporate allocations and the effects of changes in foreign currency exchange rates. For additional details, refer to Note 16 “Segment
Reporting and Geographic Information” to our Condensed Consolidated Financial Statements.
Revenues from our Semiconductor Process Control segment for the three months ended March 31, 2026 increased by 13% compared to the same period in the prior
year, primarily due to increased revenue from our memory customers, particularly related to DRAM, led by high-bandwidth memory, growth in foundry/logic, along with
higher service revenues from an increasing number of tools in our installed base. Revenues in this segment increased by 11% for the nine months ended March 31, 2026
compared to the same period in the prior year, primarily due to increased revenue from our memory customers, particularly related to DRAM, led by high-bandwidth memory,
higher revenue from advanced packaging, along with higher service revenues from an increasing number of tools in our installed base.
Revenues from our Specialty Semiconductor Process segment for the three months ended March 31, 2026 increased by 5% compared to the same period in the prior
year, primarily due to timing of shipments and higher service revenues from an increasing number of tools in our installed base. Revenues in this segment decreased by 5%
during the nine months ended March 31, 2026 compared to the same period in the prior year, attributable to lower volume of products sold, particularly in China, partially offset
by higher service revenues from an increasing number of tools in our installed base.
Revenues from our PCB and Component Inspection segment decreased by 1% during the three months ended March 31, 2026 compared to the same period in the prior
year, primarily due to revenues from our Display business being included in the prior year results, a business which has since been exited. The decrease was mostly offset by
increased revenues from PCB products, along with higher service revenues from growth in our installed base of tools. Revenues in this segment increased by 9% during the
nine months ended March 31, 2026 compared to the same period in the prior year, due to increased revenue from advanced packaging and PCB and component inspection
products, along with higher service revenues from growth in our installed base, partially offset by the exit of the Display business.
(1)

-- 39 of 62 --

Table of Contents
Below is supplementary revenue information by major product categories for the indicated periods:
(Dollar amounts in thousands)
Three Months Ended March 31, 	Q3 FY26
vs.
Q3 FY25	2026 	2025
Revenues:
Wafer Inspection 	$ 	1,739,671 	51 % $ 	1,495,685 	49 % $ 	243,986 	16 %
Patterning 	615,076 	18 % 	636,415 	21 % 	(21,339) 	(3)%
Specialty Semiconductor Process 	144,199 	4 % 	138,376 	4 % 	5,823 	4 %
PCB and Component Inspection 	95,148 	3 % 	104,254 	3 % 	(9,106) 	(9)%
Services 	774,791 	23 % 	669,208 	22 % 	105,583 	16 %
Other 	46,193 	1 % 	19,091 	1 % 	27,102 	142 %
Total 	$ 	3,415,078 	100 % $ 	3,063,029 	100 % $ 	352,049 	11 %
(Dollar amounts in thousands)
Nine Months Ended March 31, 	Q3 FY26 YTD
vs.
Q3 FY25 YTD	2026 	2025
Revenues:
Wafer Inspection 	$ 	4,849,697 	49 % $ 	4,427,238 	49 % $ 	422,459 	10 %
Patterning 	1,978,664 	20 % 	1,743,504 	20 % 	235,160 	13 %
Specialty Semiconductor Process 	366,006 	4 % 	394,165 	4 % 	(28,159) 	(7)%
PCB and Component Inspection 	292,794 	3 % 	270,489 	3 % 	22,305 	8 %
Services 	2,305,534 	23 % 	1,980,749 	22 % 	324,785 	16 %
Other 	129,225 	1 % 	165,276 	2 % 	(36,051) 	(22)%
Total 	$ 	9,921,920 	100 % $ 	8,981,421 	100 % $ 	940,499 	10 %
Revenues by region
The following is a summary of revenues by geographic region, based on ship-to location, for the indicated periods:
Three Months Ended March 31, 	Q3 FY26
vs.
Q3 FY25	(Dollar amounts in thousands) 	2026 	2025
Revenues:
Taiwan 	$ 	869,110 	25.5 % $ 	988,470 	32.3 % $ 	(119,360) 	(12)%
China 	829,583 	24.3 % 	792,884 	25.9 % 	36,699 	5 %
Korea 	681,060 	19.9 % 	378,548 	12.4 % 	302,512 	80 %
North America 	410,241 	12.0 % 	293,980 	9.6 % 	116,261 	40 %
Europe and Israel 	247,323 	7.2 % 	170,056 	5.5 % 	77,267 	45 %
Rest of Asia 	197,387 	5.8 % 	100,440 	3.3 % 	96,947 	97 %
Japan 	180,374 	5.3 % 	338,651 	11.0 % 	(158,277) 	(47)%
Total 	$ 	3,415,078 	100.0 % $ 	3,063,029 	100.0 % $ 	352,049 	11 %
Nine Months Ended March 31, 	Q3 FY26 YTD
vs.
Q3 FY25 YTD	(Dollar amounts in thousands) 	2026 	2025
Revenues:
China 	$ 	3,091,630 	31.2 % $ 	3,083,713 	34.3 % $ 	7,917 	— %
Taiwan 	2,507,705 	25.3 % 	2,331,672 	26.0 % 	176,033 	8 %
Korea 	1,459,747 	14.7 % 	974,656 	10.9 % 	485,091 	50 %
North America 	1,102,379 	11.1 % 	1,081,114 	12.0 % 	21,265 	2 %
Japan 	704,633 	7.1 % 	755,834 	8.4 % 	(51,201) 	(7)%
Europe and Israel 	559,469 	5.6 % 	449,142 	5.0 % 	110,327 	25 %
Rest of Asia 	496,357 	5.0 % 	305,290 	3.4 % 	191,067 	63 %
Total 	$ 	9,921,920 	100.0 % $ 	8,981,421 	100.0 % $ 	940,499 	10 %

-- 40 of 62 --

Table of Contents
Revenues from our customers in China increased 5% and by less than 1% in the three and nine months ended March 31, 2026, respectively, compared to the same periods
in the prior year, primarily due to continued legacy node demand, partially offset by the effects of U.S. export controls and regulations.
Revenues from our customers in Taiwan decreased 12% in the three months ended March 31, 2026 compared to the same period in the prior year, primarily due to the
timing of shipments. Revenues from customers in Taiwan increased 8% in the nine months ended March 31, 2026, compared to the same period in the prior year, primarily due
to increased investments in process control to meet leading-edge demand driven by innovation and growth of AI.
Revenues from our customers in Korea increased 80% and 50% in the three and nine months ended March 31, 2026, respectively, compared to the same periods in the
prior year, primarily due to increased investments from our memory customers. Revenues from our customers in North America increased 40% in the three months ended
March 31, 2026 compared to the same period in the prior year, due to increased investments from both memory and foundry/logic customers. Revenues from customers in
North America increased 2% in the nine months ended March 31, 2026, compared to the same period in the prior year, primarily due to increased investments from memory
customers and continued legacy node demand, partially offset by lower shipments to foundry/logic customers. Revenues from our customers in Japan decreased 47% in the
three months ended March 31, 2026 compared to the same period in the prior year, due to decreased investments from customers in the semiconductor process control segment.
The remaining regions accounted for less than 10% of total revenues individually in the periods presented.
Gross margin
Our gross margin fluctuates with revenue levels and product mix and is affected by variations in costs related to manufacturing and servicing our products, including our
ability to scale our operations efficiently and effectively in response to prevailing business conditions.
The following table summarizes the major factors that contributed to the changes in gross margin:
Gross Margin
Three Months Ended 	Nine Months Ended
March 31, 2025 	61.6% 	60.5%
Revenue volume of products and services 	0.5% 	0.4%
Mix of products and services sold 	(0.5)% 	0.5%
Manufacturing labor, overhead and efficiencies 	(0.1)% 	0.1%
Other service and manufacturing costs 	(0.4)% 	(0.2)%
March 31, 2026 	61.1% 	61.3%
Changes in gross margin from revenue volume of products and services reflect our ability to leverage existing infrastructure to generate higher revenues. Changes in
gross margin from the mix of products and services sold reflect the impact of changes within the composition of product and service offerings. Changes in gross margin from
manufacturing labor, overhead and efficiencies reflect our ability to manage costs and drive productivity as we scale our manufacturing activity to respond to customer
requirements and amortization of intangible assets. In both the three and nine months ended March 31, 2026, manufacturing labor, overhead and efficiencies included increased
employee-related costs due to increases in headcount offset by absorption benefits from better build plans, compared to the same periods in the prior year. Changes in gross
margin from other service and manufacturing costs include the impact of tariffs, customer support costs, including the efficiencies with which we deliver services to our
customers, and the effectiveness with which we manage our production plans and inventory risk. In both the three and nine months ended March 31, 2026, other service and
manufacturing costs included higher installation and warranty costs and increased costs due to tariffs, partially offset by lower inventory-related charges, compared to the same
periods in the prior year.
Research and Development
R&D expenses may fluctuate with product development phases and project timing as well as our R&D efforts. As technological innovation is essential to our success, we
may incur significant costs associated with R&D projects, including compensation for engineering talent, engineering material costs and other expenses.

-- 41 of 62 --

Table of Contents
(Dollar amounts in thousands)
Three Months Ended March 31, 	Q3 FY26
vs.
Q3 FY25	2026 	2025
R&D expenses 	$ 	388,763 	$ 	338,043 	$ 	50,720 	15 %
R&D expenses as a percentage of total revenues 	11 % 	11 %
R&D expenses during the three months ended March 31, 2026 increased compared to the three months ended March 31, 2025 primarily due to increases in employee-
related expenses of $35.7 million as a result of additional headcount and higher employee compensation and benefit costs, and engineering project material costs of $7.3
million.
(Dollar amounts in thousands)
Nine Months Ended March 31, 	Q3 FY26 YTD
vs.
Q3 FY25 YTD	2026 	2025
R&D expenses 	$ 	1,133,095 	$ 	1,007,345 	$ 	125,750 	12 %
R&D expenses as a percentage of total revenues 	11 % 	11 %
R&D expenses during the nine months ended March 31, 2026 increased compared to the nine months ended March 31, 2025 primarily due to increases in employee-
related expenses of $87.6 million as a result of additional headcount and higher employee compensation and benefit costs, and engineering project material costs of $31.9
million.
Our future operating results will depend significantly on our ability to make products and provide services that have a competitive advantage in our marketplace. To do
this, we believe that we must continue to make substantial and focused investments in our R&D. We remain committed to product development in new and emerging
technologies.
Selling, General and Administrative
Three Months Ended March 31, 	Q3 FY26
vs.
Q3 FY25	(Dollar amounts in thousands) 	2026 	2025
SG&A expenses 	$ 	291,134 	$ 	248,905 	$ 	42,229 	17 %
SG&A expenses as a percentage of total revenues 	9 % 	8 %
SG&A expenses during the three months ended March 31, 2026 increased compared to the three months ended March 31, 2025 primarily due to increases in provision for
credit losses of $23.1 million, employee-related expenses of $14.9 million as a result of additional headcount and higher employee compensation and benefit costs, and
facilities-related expense of $6.6 million.
(Dollar amounts in thousands)
Nine Months Ended March 31, 	Q3 FY26 YTD
vs.
Q3 FY25 YTD	2026 	2025
SG&A expenses 	$ 	840,041 	$ 	767,028 	$ 	73,013 	10 %
SG&A expenses as a percentage of total revenues 	8 % 	9 %
SG&A expenses during the nine months ended March 31, 2026 increased compared to the nine months ended March 31, 2025 primarily due to increases in provision for
credit losses of $26.1 million, facilities-related expense of $20.3 million, and employee-related expenses of $17.6 million as a result of additional headcount and higher
employee compensation and benefit costs.
Restructuring Charges
Restructuring charges were $0.2 million and $0.6 million for the three months ended March 31, 2026 and 2025, respectively. Restructuring charges were $0.9 million and
$5.6 million for the nine months ended March 31, 2026 and 2025, respectively. For additional information, refer to Note 17 “Restructuring Charges” to our Condensed
Consolidated Financial Statements.
Interest Expense and Other Expense (Income), Net
Other expense (income), net is comprised primarily of fair value adjustments and realized gains or losses on sales of marketable and non-marketable securities, gains or
losses from revaluations of certain foreign currency denominated assets and liabilities as well as foreign currency contracts, interest-related accruals (such as interest and
penalty accruals related to our tax

-- 42 of 62 --

Table of Contents
obligations) and interest income earned on our invested cash, cash equivalents and marketable securities.
(Dollar amounts in thousands)
Three Months Ended March 31, 	Q3 FY26
vs.
Q3 FY25	2026 	2025
Interest expense 	$ 	70,423 	$ 	71,889 	$ 	(1,466) 	(2)%
Other expense (income), net 	$ 	(79,675) 	$ 	(35,930) 	$ 	(43,745) 	(122)%
Interest expense as a percentage of total revenues 	2 % 	2 %
Other expense (income), net as a percentage of total revenues 	(2)% 	(1)%
Interest expense during the three months ended March 31, 2026 was comparable to the three months ended March 31, 2025, as average outstanding debt was essentially
unchanged.
The change in other expense (income), net during the three months ended March 31, 2026 compared to the three months ended March 31, 2025 was primarily due to a net
fair value gain of $31.9 million from an equity security, favorable foreign exchange fluctuations of $12.4 million, and higher interest income of $4.1 million.
(Dollar amounts in thousands)
Nine Months Ended March 31, 	Q3 FY26 YTD
vs.
Q3 FY25 YTD	2026 	2025
Interest expense 	$ 	211,166 	$ 	229,041 	$ 	(17,875) 	(8)%
Other expense (income), net 	$ 	(160,874) 	$ 	(121,323) 	$ 	(39,551) 	(33)%
Interest expense as a percentage of total revenues 	2 % 	3 %
Other expense (income), net as a percentage of total revenues 	(2)% 	(1)%
Interest expense during the nine months ended March 31, 2026 decreased compared to the nine months ended March 31, 2025 primarily due to reduced interest expense
following our $750.0 million debt repayment in the second quarter of fiscal 2025.
The change in other expense (income), net during the nine months ended March 31, 2026 compared to the nine months ended March 31, 2025 was primarily due to a net
fair value gain of $35.1 million from an equity security, favorable foreign exchange fluctuations of $13.4 million, partially offset by lower interest income of $4.3 million.
Provision for Income Taxes
The following table provides details of income taxes:
Three Months Ended March 31, 	Nine Months Ended March 31,
(Dollar amounts in thousands) 	2026 	2025 	2026 	2025
Income before income taxes 	$ 	1,416,761 	$ 	1,264,433 	$ 	4,056,540 	$ 	3,315,649
Provision for income taxes 	$ 	215,771 	$ 	176,017 	$ 	588,828 	$ 	456,855
Effective tax rate 	15.2 % 	13.9 % 	14.5 % 	13.8 %
The effective tax rate during the three months ended March 31, 2026 was higher compared to the three months ended March 31, 2025, primarily due to a decrease in the
proportion of earnings generated in jurisdictions with tax rates lower than the U.S. statutory rates and a decrease in the proportion of U.S. earnings eligible for the Foreign
Derived Intangible Income deduction, partially offset by a decrease in our Global Intangible Low-Taxed Income.
The effective tax rate during the nine months ended March 31, 2026 was higher compared to the nine months ended March 31, 2025, primarily due to a decrease in the
proportion of earnings generated in jurisdictions with tax rates lower than the U.S. statutory rates and a decrease in the proportion of U.S. earnings eligible for the Foreign
Derived Intangible Income deduction, partially offset by a decrease in our Global Intangible Low-Taxed Income and a $230.4 million goodwill impairment charge during the
nine months ended March 31, 2024 which is non-deductible for income tax.
Our future effective income tax rate depends on various factors, such as tax legislation, the geographic composition of our pre-tax income, the amount of our pre-tax
income as business activities fluctuate, non-deductible expenses incurred in connection with acquisitions, R&D credits as a percentage of aggregate pre-tax income, non-taxable
or non-deductible increases or decreases in the assets held within our Executive Deferred Savings Plan, the tax effects of employee stock activity and the effectiveness of our
tax planning strategies. We also continue to monitor the adoption of Pillar Two relating to the global minimum tax in each of our tax jurisdictions to evaluate its impact on our
effective income tax rate. For some of the

-- 43 of 62 --

Table of Contents
jurisdictions that have adopted Pillar Two in their tax legislation, it was effective for us beginning in our fiscal year ended June 30, 2025.
For discussions on tax examinations, assessments and certain related proceedings, see Note 12 “Income Taxes” to our Condensed Consolidated Financial Statements.
LIQUIDITY AND CAPITAL RESOURCES
As of 	As of
(Dollar amounts in thousands) 	March 31, 2026 	June 30, 2025
Cash and cash equivalents 	$ 	1,787,010 	$ 	2,078,908
Marketable securities 	3,170,928 	2,415,715
Total cash, cash equivalents and marketable securities 	$ 	4,957,938 	$ 	4,494,623
Percentage of total assets 	29 % 	28 %
Nine Months Ended March 31,
(In thousands) 	2026 	2025
Cash flows:
Net cash provided by operating activities 	$ 	3,236,649 	$ 	2,916,912
Net cash provided by (used in) investing activities 	(1,016,978) 	122,864
Net cash used in financing activities 	(2,508,530) 	(3,155,874)
Effect of exchange rate changes on cash and cash equivalents 	(3,039) 	(3,009)
Net decrease in cash and cash equivalents 	$ 	(291,898) 	$ 	(119,107)
Cash, Cash Equivalents and Marketable Securities
As of March 31, 2026, our cash, cash equivalents and marketable securities totaled $4.96 billion, compared to the $4.49 billion balance as of June 30, 2025. Refer to
below discussions of sources and uses of cash during the nine months ended March 31, 2026. As of March 31, 2026, $1.09 billion of our $4.96 billion of cash, cash equivalents
and marketable securities were held by our foreign subsidiaries and branch offices. We have recorded appropriate provisions for income or withholding taxes that may result
from future repatriations of this balance.
Cash Flows Provided by Operating Activities
We typically finance our liquidity requirements through cash generated from our operations. Net cash provided by operating activities during the nine months ended
March 31, 2026 was $3.24 billion compared to $2.92 billion during the nine months ended March 31, 2025. This increase was primarily due to an increase in customer and
other collections of approximately $960 million primarily driven by higher shipments, a decrease in income tax payments of approximately $73 million and a decrease in other
tax payments of approximately $30 million; partially offset by increases in accounts payable payments of approximately $580 million and employee-related payments of
approximately $165 million.
Cash Flows Used in Investing Activities
Net cash used in investing activities during the nine months ended March 31, 2026 was $1.02 billion compared to $122.9 million of net cash provided during the nine
months ended March 31, 2025. This increase in cash used was primarily due to increases in net purchases of available-for-sale securities of $1.11 billion, and capital
expenditures of $51.8 million, partially offset by a $16.5 million increase in proceeds from capital-related government assistance.
Cash Flows Used in Financing Activities
Net cash used in financing activities during the nine months ended March 31, 2026 was $2.51 billion compared to $3.16 billion during the nine months ended March 31,
2025. This decrease in cash used was primarily due to a $750.0 million debt repayment during the nine months ended March 31, 2025 and a decrease in common stock
repurchases of $5.5 million, partially offset by increases in payment of dividends and dividend equivalents of $101.9 million and tax withholding payments related to vested
and released restricted stock units (“RSU”) of $12.7 million.

-- 44 of 62 --

Table of Contents
Stock Repurchases
The shares of common stock repurchased under our stock repurchase program have reduced our basic and diluted weighted-average shares outstanding for the nine
months ended March 31, 2026 and 2025. The total amount of stock repurchases during the nine months ended March 31, 2026 and 2025 were $1.72 billion for both periods.
The stock repurchase program is intended, in part, to mitigate the potential dilutive impact related to our equity incentive plans and shares issued in connection with our
Employee Stock Purchase Program as well as to return excess cash to our stockholders. As of March 31, 2026, an aggregate of $10.31 billion was available for repurchase
under our stock repurchase program, which reflects an increase in the authorized repurchase amount of $7.00 billion in the third quarter of fiscal 2026.
Cash Dividends
During the three months ended March 31, 2026, our Board of Directors declared a regular quarterly cash dividend of $1.90 per share on our outstanding common stock,
which was paid on March 3, 2026 to our stockholders of record as of the close of business on February 17, 2026. During the same period in fiscal year ended June 30, 2025, our
Board of Directors declared and paid a regular quarterly cash dividend of $1.70 per share on our outstanding common stock. The total amount of regular quarterly cash
dividends and dividend equivalents paid during the three months ended March 31, 2026 and 2025 was $248.8 million and $225.8 million, respectively. The total amount of
regular quarterly cash dividends and dividend equivalents paid during the nine months ended March 31, 2026 and 2025 was $752.5 million and $650.6 million, respectively.
The amount of accrued dividend equivalents payable for regular quarterly cash dividends on unvested RSUs with dividend equivalent rights as of March 31, 2026 and June 30,
2025 was $15.8 million and $13.3 million, respectively. These amounts will be paid upon vesting of the underlying unvested RSUs as described in Note 9 “Equity and Long-
term Incentive Compensation Plans” to our Condensed Consolidated Financial Statements.
Senior Notes
As of March 31, 2026, we had an aggregate principal amount of senior, unsecured notes totaling $5.95 billion (collectively, “Senior Notes”) with due dates ranging from
fiscal 2029 through fiscal 2063. For additional information on these Senior Notes, see Note 7 “Debt” to our Condensed Consolidated Financial Statements. As of March 31,
2026, we were in compliance with all of our covenants under the Indenture associated with the Senior Notes.
Revolving Credit Facility
We have in place a Credit Agreement (“Credit Agreement”) for an unsecured Revolving Credit Facility (“Revolving Credit Facility”) with a maturity date of July 3, 2030
that allows us to borrow up to $1.50 billion. Subject to the terms of the Credit Agreement, the Revolving Credit Facility may be increased by an amount up to $500.0 million in
the aggregate. As of March 31, 2026, we had no outstanding borrowings under the Revolving Credit Facility. We were in compliance with all covenants under the Credit
Agreement as of March 31, 2026 (the net leverage ratio was 0.54 to 1.00, compared to a maximum net leverage ratio of 3.25 to 1.00 on a quarterly basis covering the trailing
four consecutive fiscal quarters for each fiscal quarter). Considering our current liquidity position, short-term financial forecasts and ability to prepay the Revolving Credit
Facility, if necessary, we expect to continue to be in compliance with our financial covenants at the end of our fiscal year ending June 30, 2026.
For additional information on the Revolving Credit Facility, see Note 7 “Debt” to our Condensed Consolidated Financial Statements.
Material Cash Requirements
For details regarding our debt and other material cash commitments, refer to Note 7 “Debt” and Note 14 “Commitments and Contingencies,” respectively, to our
Condensed Consolidated Financial Statements. For additional details regarding our material cash requirements, refer to “Material Cash Requirements” in the “Liquidity and
Capital Resources” section of Part II, Item 7 “Management’s Discussion and Analysis of Financial Condition and Results of Operations” in our Annual Report on Form 10-K
for the fiscal year ended June 30, 2025.
Off-Balance Sheet Arrangements
As of March 31, 2026, we did not have any off-balance sheet arrangements that have or are reasonably likely to have a current or future effect on our financial position,
changes in financial condition, revenues and expenses, results of operations, liquidity, capital expenditures or capital resources that are material to investors. Refer to Note 14
“Commitments and Contingencies” to our Condensed Consolidated Financial Statements for information related to indemnification obligations.

-- 45 of 62 --

Table of Contents
Working Capital
Working capital was $7.60 billion as of March 31, 2026, which represents an increase of $986.4 million compared to our working capital of $6.61 billion as of June 30,
2025. As of March 31, 2026, our principal sources of liquidity consisted of $4.96 billion of cash, cash equivalents and marketable securities, as well as $1.50 billion availability
under our Revolving Credit Facility. Our liquidity may be affected by many factors, some of which are based on the normal ongoing operations of the business, spending for
business acquisitions, and other factors such as uncertainty in the global and regional economies and the semiconductor, semiconductor-related and electronic device industries.
Although cash requirements will fluctuate based on the timing and extent of these factors, we believe that cash generated from operations, together with the liquidity provided
by existing cash and cash equivalents balances, marketable securities and our Revolving Credit Facility, will be sufficient to satisfy our liquidity requirements associated with
working capital needs, capital expenditures, cash dividends, stock repurchases and other contractual obligations for at least the next 12 months.
Credit Ratings
Our credit ratings as of March 31, 2026 are summarized below:
Rating Agency 	Rating
Fitch Inc. 	A
Moody’s Investors Service 	A2
S&P Global Ratings 	A-
Factors that can affect our credit ratings include changes in our operating performance, the economic environment, conditions in the semiconductor and semiconductor
capital equipment industries, our financial position, material acquisitions and changes in our business strategy.
ITEM 3. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK
There have been no material changes in our interest rate risk, marketable equity security risk or foreign currency risk since our Annual Report on Form 10-K for the fiscal
year ended June 30, 2025. Refer to “Quantitative and Qualitative Disclosures About Market Risk” contained in Part II, Item 7A of our Annual Report on Form 10-K for our
fiscal year ended June 30, 2025 for a complete description of our market risk.
ITEM 4. CONTROLS AND PROCEDURES
Evaluation of Disclosure Controls and Procedures and Related CEO and CFO Certifications
Evaluation of Disclosure Controls and Procedures
We conducted an evaluation of the effectiveness of the design and operation of our disclosure controls and procedures (as defined in Rules 13a-15(e) and 15d-15(e) under
the Exchange Act (“Disclosure Controls”) as of the end of the period covered by this Quarterly Report on Form 10-Q (this “Report”) required by Exchange Act Rules 13a-15(b)
or 15d-15(b). The Disclosure Controls evaluation was conducted under the supervision and with the participation of our management, including our Chief Executive Officer
(“CEO”) and Chief Financial Officer (“CFO”). Based on this evaluation, the CEO and CFO have concluded that, as of the end of the period covered by this Report, our
Disclosure Controls were effective at a reasonable assurance level.
Attached as exhibits to this Report are certifications of the CEO and CFO that are required in accordance with Rule 13a-14 of the Exchange Act. This Controls and
Procedures section includes the information concerning the controls evaluation referred to in the certifications, and it should be read in conjunction with the certifications for a
more complete understanding of the topics presented.
Definition of Disclosure Controls
Disclosure Controls are controls and procedures designed to reasonably ensure that information required to be disclosed in our reports filed or submitted under the
Exchange Act, such as this Report, is recorded, processed, summarized and reported within the time periods specified in the U.S. Securities and Exchange Commission’s rules
and forms. Disclosure Controls are also designed to provide reasonable assurance that such information is accumulated and communicated to our management, including our
CEO and CFO, as appropriate to allow timely decisions regarding required disclosure. Our Disclosure Controls include components of our internal control over financial
reporting, which consists of control processes designed to provide reasonable assurance regarding the reliability of our financial reporting and the preparation of financial
statements in accordance with generally accepted accounting principles in the United States of America. To the extent that components of our

-- 46 of 62 --

Table of Contents
internal control over financial reporting are included within our Disclosure Controls, they are included in the scope of our annual controls evaluation.
Limitations on the Effectiveness of Disclosure Controls
Our management, including our CEO and CFO, does not expect that our Disclosure Controls or internal control over financial reporting will prevent all error and fraud. A
control system, no matter how well designed and operated, can provide only reasonable, not absolute, assurance that the control system’s objectives will be met. Further, the
design of a control system must reflect the fact that there are resource constraints, and the benefits of controls must be considered relative to their costs. Because of the inherent
limitations in all control systems, no evaluation of controls can provide absolute assurance that all control issues and instances of fraud, if any, within the Company have been
detected. These inherent limitations include the realities that judgments in decision making can be faulty and that breakdowns can occur because of simple errors or mistakes.
Controls can also be circumvented by the individual acts of some persons, by collusion of two or more people, or by management override of the controls. The design of any
system of controls is based in part on certain assumptions about the likelihood of future events, and there can be no assurance that any design will succeed in achieving our
stated goals under all potential future conditions. Over time, controls may become inadequate because of changes in conditions or deterioration in the degree of compliance
with policies or procedures. Because of the inherent limitations in a cost-effective control system, misstatements due to error or fraud may occur and not be detected.
Changes in Internal Control over Financial Reporting
There were no changes in our internal control over financial reporting identified in connection with the evaluation required by Rule 13a-15(d) and 15d-15(d) of the
Exchange Act that occurred during the most recent fiscal quarter covered by this Report that have materially affected, or are reasonably likely to materially affect, our internal
control over financial reporting.

-- 47 of 62 --

Table of Contents
PART II. OTHER INFORMATION
ITEM 1. LEGAL PROCEEDINGS
The information set forth above under Note 13 “Litigation and Other Legal Matters” to our Condensed Consolidated Financial Statements in Item 1 of Part 1 is
incorporated herein by reference.
ITEM 1A. RISK FACTORS
Other than the risk factors listed below, there have been no material changes in our risk factors since our Annual Report on Form 10-K for the fiscal year ended June 30,
2025. Refer to “Risk Factors” contained in Part I Item 1A of our Annual Report on Form 10-K for our fiscal year ended June 30, 2025 for a complete description of our risk
factors. Any of these risks, as well as risks unknown to us or that we believe are currently immaterial, could have a material adverse impact on our business, financial condition
or results of operations.
Over the past several years, there have been a variety of rules and regulations issued by Commerce that have had an impact on our ability to sell certain products and
provide certain services to certain customers in China. These rules and regulations may significantly harm our business, results of operations, financial condition and cash
flows in future periods, unless we are able to obtain required licenses.
We maintain significant operations outside the United States, and existing and evolving trade restrictions imposed by the U.S. and other governments could significantly
disrupt our global operations. The U.S. government has tightened export controls for commodities, software, and technology (collectively, “items”) destined to China over the
past several years. These controls have included, for example, restrictions on exporting certain items to military end users and for military end uses, the addition of numerous
entities to the U.S. Entity List (a list of parties that are generally ineligible to receive U.S.-regulated items without prior licensing from Commerce), and the creation of new
licensing requirements that apply to the export, re-export, and transfer of certain foreign-made items that are the direct product of U.S. origin technology or produced by a plant
or major component of a plant that itself is the direct product of U.S. origin technology and which are destined to Huawei or its affiliates and other specified companies on the
U.S. Entity List, and other facilities in China where the production of advanced node IC occurs.
In October 2022, Commerce published the 2022 BIS Rules (the “2022 BIS Rules”) that introduced restrictions related to semiconductor, semiconductor manufacturing,
supercomputer, and advanced computing items and end uses. These rules impose restrictions on our ability to sell, ship and support certain equipment and otherwise conduct
business with certain counterparties, primarily including China-based companies involved in advanced semiconductor manufacturing. Further, the 2022 BIS Rules impose
restrictions on the activities of U.S. persons with respect to certain items that are not subject to the Export Administration Regulations (“EAR”), which departs from
Commerce’s typical practice of controlling items that are subject to the EAR, and could further restrict our ability to conduct business in China. In October 2023, Commerce
issued the 2023 BIS Rules (the “2023 BIS Rules”) designed to update export controls on advanced computing semiconductors and semiconductor manufacturing equipment, as
well as items that support supercomputing applications and end-uses, to certain D1, D4 and/or D5 countries in Supplement No. 1 of Part 740 of the U.S. EAR, including China.
The 2023 BIS Rules adjust the parameters included in the 2022 BIS Rules that determine whether an advanced computing chip is restricted and impose new measures to
address risks of circumvention of the controls established by the 2022 BIS Rules.
In December 2024 and January 2025, Commerce again issued incremental 2024 BIS Rules and 2025 BIS Rules, adding even more companies to the U.S. Entity List and
revising the definition of advanced DRAM, further restricting our ability to provide certain items and services to facilities in China producing advanced DRAM ICs.
In September 2025, Commerce released an interim final rule that further expands export control restrictions and licensing requirements for foreign entities 50% or more
directly or indirectly owned by one or more listed parties on the U.S. Entity List, Military End-User List, and certain entities on the Specially Designated Nationals and Block
Persons List, which Commerce has labeled the “Affiliates Rule.” The new rule increases compliance requirements with the EAR by imposing on exporters, re-exporters, and
transferors of items subject to the EAR a responsibility to know the ownership of the parties to a transaction. In November 2025, the BIS suspended the Affiliates Rule for one
year until November 2026.
Commerce may continue to add China-based entities to the U.S. Entity List and impose other end use or end user export restrictions, which could disrupt or prevent our
product shipment, and further disrupt our revenue recognition, business operations and our ability to support our customers in China.
These rules and regulations may significantly harm our business unless we are able to obtain required licenses. We will continue to apply for export licenses, when
required, in an effort to avoid disruption to our and our customers’ operations, but

-- 48 of 62 --

Table of Contents
there can be no assurance that export licenses applied for by either us or our customers, now or in the future, will be granted. To the extent Commerce does issue licenses to us
or to our customers, such licenses may have a short duration or require us to satisfy various conditions. If pending and future export license applications are not granted, or
additional restrictions are imposed, or if regulators adopt new interpretations of existing regulations, the potential impact on us could be material by disrupting our supply chain
and product shipment, impairing our ability to complete product development in a timely manner, or our ability to support existing customers of covered products or supply
customers of covered products outside the impacted regions, and requiring us to transition certain operations out of one or more of the identified countries. Failure to obtain
export licenses has harmed and could continue to harm our backlog, requiring us to return substantial deposits received from customers in China for purchase orders, and/or
further limiting our ability to meet our contractual obligations and sell our products or provide services to our customers in China. In addition, the U.S. export restrictions on
semiconductors and semiconductor technology to China and Chinese customers may reduce the need for our products and make it easier for our China-based competitors to
develop and sell their own products and take market share from us.
We may lose revenue in future periods related to anticipated sales to customers in China unless we are able to replace their orders with other customer orders for which
either an export license has been obtained or is not required. Our revenue from sales of products and provision of services to customers in China was 33%, 43% and 27% for
fiscal years 2025, 2024 and 2023, respectively, and future revenue from China as a percentage of our overall revenue may decline as a result of the current and future
Commerce rules and regulations.
Additionally, the Chinese government has adopted, and may further adopt, new regulations, in response to U.S. government actions, which could adversely affect our
ability to do business in China.
We have faced delays and could face additional delays or denials in the export of our tools by regulatory agencies for national security or other regulatory concerns in the
countries in which we do business, which could negatively affect our results of operations and timing of revenue recognition. We have controls and procedures designed to
maintain compliance with U.S. and other applicable export control laws and regulations; however, we cannot guarantee that such controls and procedures will be successful in
preventing violations or allegations of violations, of increasingly complex and often conflicting regulations worldwide. Recently, some of our products destined for China have
been held up by U.S. Customs and Border Protection due to questions about the nature of the customer or about the capabilities of our products. We cannot make any assurance
that products that have been held up will be cleared for shipment in a timely manner or without a license. Shipment delays or cancellations could have an adverse effect on our
financial condition and results of operations. The complexity and evolving nature of the rules and regulations, and the fact that Commerce or other relevant regulators might
adopt interpretations of regulations that differ from those of the Company, increase our risk of non-compliance.
Any violations by us of applicable export laws and regulations could result in significant civil and criminal penalties, including fines and criminal proceedings against the
Company or responsible employees, a denial of export privileges, suspension or debarment. Our employees, customers, suppliers or other third parties with whom we work
may also engage in conduct for which the Company might be held responsible. We could face significant compliance, litigation or settlement costs and diversion of
management’s attention from our business as a result. Further, the Company may be subject to negative publicity or reputational harm, resulting in reduced demand for our
products, employee attrition and other negative impact on our business, results of operations, financial condition and cash flows.
Recently announced and future U.S. tariffs or other restrictions placed on imports, retaliatory trade measures taken by other countries and resulting trade wars may
have a material adverse impact on our results of operations.
In 2025, the U.S. implemented a number of tariffs on goods imported into the U.S., on a country and industry-specific basis (including aluminum, copper and steel).
While some of the U.S. Tariffs have been paused, certain U.S. Tariffs are currently in effect, including a base tariff on nearly all imports into the U.S., certain reciprocal tariffs
by country, and certain sectoral tariffs on copper, aluminum and steel, among others. In retaliation to the tariffs imposed on U.S. imports, a number of other countries
announced reciprocal tariffs on goods imported from the U.S. While most countries paused their reciprocal tariffs on U.S. imported goods, those reciprocal tariffs could be
reinstated at any time. Tariffs imposed by the U.S. on goods imported into the U.S. and tariffs imposed by other countries on U.S. goods imported into those countries may
continue to evolve.
In April 2025, Commerce announced the initiation of investigations into the effects on U.S. national security of imports of semiconductors under Section 232 of the Trade
Expansion Act of 1962. The scope of the investigations include semiconductors, semiconductor manufacturing equipment and their derivative products including
semiconductor substrates and bare wafers, legacy chips, leading-edge chips, microelectronics and other components. While the results of the investigations are currently
unknown, they may result in additional tariffs and trade restrictions which may adversely impact our business.

-- 49 of 62 --

Table of Contents
In February 2026, the U.S. Supreme Court ruled that tariffs imposed under the International Emergency Economic Powers Act were not authorized, creating uncertainty
around the status of prior tariffs, potential refund processes and the scope of future presidential tariff authority. This ruling adds volatility to an already fluid tariff environment
and may result in rapid changes in tariff rates, shifts in enforcement, delays in customs processing and increased uncertainty in supply chain and capital planning for us and our
customers.
The U.S. Tariffs have increased our cost of revenues due to the increase in the cost of importing foreign sourced components to our U.S. facilities to build the products
that we manufacture in the U.S. Tariffs imposed on U.S. goods by other countries may harm demand for our products from customers in those regions, or may cause our
customers in those regions to push out or cancel previously placed purchase orders. In addition, we have had to return deposits given to us by our customers upon cancellation
of their purchase orders. Moreover, tariffs can make it difficult for us and our customers and suppliers to make and execute business and capital equipment investment plans or
increase supply chain complexity, which may have an impact on our ability to source the materials necessary to manufacture our products.
Our efforts to address these risks, such as through operational adjustments and pricing strategies, may not be successful. Such efforts may need time to take effect and
may have an adverse impact on our results of operations.
Unless rescinded or exemptions apply, tariffs and any escalations in the trade war could significantly harm our business, financial condition and results of operations.
We rely upon certain critical information systems for our daily business operations. Our inability to use or access our information systems at critical points in time
could unfavorably impact our business operations.
Our global operations are dependent upon certain information systems, including telecommunications, the internet, our corporate intranet, network communications,
email and various computer hardware and software applications. System failures or malfunctions, such as difficulties with our customer and supplier relationship management
systems, could disrupt our operations and our ability to timely and accurately process and report key components of our financial results. Our enterprise resource planning
(“ERP”) system is integral to our ability to accurately and efficiently maintain our books and records, record transactions, provide critical information to our management, and
prepare our financial statements. We are currently upgrading our ERP system, with implementation expected to be completed in the first quarter of fiscal year 2027.
Implementation of an upgrade to an ERP system requires the investment of significant resources and could lead to data migration issues, administrative and technical problems,
and delays. Moreover, once our ERP system is upgraded, it may not operate as we expect it to. Any disruptions or difficulties that may occur in connection with our ERP system
or other systems (whether in connection with the regular operation, periodic enhancements, modifications or upgrades of such systems or the integration of our acquired
businesses into such systems, or due to cybersecurity events such as ransomware attacks, including attacks on the information systems of our business partners and other third
parties) could adversely affect our ability to complete important business processes, such as the evaluation of our internal controls over financial reporting pursuant to
Section 404 of the Sarbanes-Oxley Act of 2002. Any of these events could have an adverse effect on our business, operating results and financial condition.
We are predominantly uninsured for losses and interruptions caused by terrorist acts and acts of war. If international political instability or geopolitical tensions
continue or increase, our business and results of operations could be harmed.
The threat of terrorism targeted at, or acts of war in, the regions of the world in which we do business increases the uncertainty in our markets. Any act of terrorism or
war that affects the economy or the industries we serve could adversely affect our business. Increased international political instability or geopolitical tensions in various parts
of the world, disruption in air transportation and further enhanced security measures as a result of terrorist attacks may hinder our ability to do business and may increase our
costs of operations.
We maintain significant operations in Israel. Since the establishment of the State of Israel in 1948, a number of armed conflicts have taken place between Israel and its
Arab neighbors, and a state of hostility varying in degree and intensity has led to security and economic challenges for Israel. Persistent hostilities involving Iran and Iran-
backed groups, including Hezbollah in Lebanon and Hamas in the Gaza Strip, have involved missile strikes against civilian targets in various parts of Israel and attacks on
marine vessels traversing the Red Sea. The recent escalation of conflicts in the region has heightened instability, disrupted airspace, and increased freight and insurance costs.
Disruptions in shipping routes in the Red Sea could result in delays in shipping our products to customers, which could delay the timing of revenue recognition and create
uncertainty related to timeliness of shipments from the region. In addition, some of our employees in Israel are obligated to perform annual reserve duty in the Israel Defense
Forces, and may be called to active military duty in emergency circumstances. The ongoing conflicts, including additional military actions, retaliatory measures, sanctions,
cyberattacks, or other governmental or market responses, could lead to further disruption of global energy supplies, heighten inflationary pressures on our input costs, adversely
affect global supply chains, commodity prices, currency exchange rates, financial markets and overall

-- 50 of 62 --

Table of Contents
macroeconomic conditions. These developments could impact our ability to operate our business directly and indirectly through a similar impact on our suppliers and
customers.
A change in our effective tax rate can have a significant adverse impact on our business.
We earn profits in, and are therefore potentially subject to taxes in, the U.S. and numerous foreign jurisdictions, including Singapore and Israel, the countries in which we
earn the majority of our non-U.S. profits. Due to economic, political or other conditions, tax rates in those jurisdictions may be subject to significant change. A number of
factors may adversely impact our future effective tax rates, such as the jurisdictions in which our profits are determined to be earned and taxed; changes in the tax rates imposed
by those jurisdictions; expiration of tax holidays in certain jurisdictions that are not renewed; the resolution of issues arising from tax audits with various tax authorities;
changes in the valuation of our deferred tax assets and liabilities; adjustments to estimated taxes upon finalization of various tax returns; increases in expenses not deductible
for tax purposes, including write-offs of acquired in-process research and development and impairment of goodwill in connection with acquisitions; changes in available tax
credits; changes in stock-based compensation expense; changes in tax laws or the interpretation of such tax laws; changes in generally accepted accounting principles; and the
repatriation of earnings from outside the U.S. for which we have not previously provided for U.S. taxes. A change in our effective tax rate can materially and adversely impact
our results from operations.
In addition, changes to U.S. tax laws will significantly impact how U.S. multinational corporations are taxed on U.S. and foreign earnings. On July 4, 2025, the
enactment of the One Big Beautiful Bill Act (“OBBBA”) provides for several permanent changes to the U. S. tax code including, among other items, modifying the Global
Intangible Low-Taxed Income (“GILTI”) and Foreign-Derived Intangible Income (“FDII”) rules that were included in the Tax Cuts and Jobs Act, which was enacted into law
on December 22, 2017.
The OBBBA renames GILTI to Net Controlled Foreign Corporation (“CFC”) Tested Income (“NCTI”) and modifies the percentage of foreign earnings under the GILTI
regime that is taxable in the U.S. from 50% to 40% for tax years beginning after December 31, 2025. It also renames FDII to Foreign-Derived Deduction Eligible Income
(“FDDEI”) and modifies the percentage of U.S. earnings under the FDII regime that is not subject to tax in the U.S. from 37.5% to 33.34% for tax years beginning after
December 31, 2025. The net impact of the changes provided by the OBBBA and interpretations of such law may have a material and adverse impact to our effective tax rate.
On August 16, 2022, the enactment of the Inflation Reduction Act (“IRA”) introduced a corporate alternative minimum tax (“CAMT”) that was effective for us beginning
in the quarter ended September 30, 2023. The CAMT applies a 15% minimum income tax rate on certain large corporations. Although we were not subject to the CAMT in our
fiscal year ended June 30, 2025, the enactment of the OBBBA and interpretations of such law may result in our subjection to CAMT liability in future periods, which can have
a material and adverse impact to our future effective tax rate.
Numerous countries are evaluating their existing tax laws due, in part, to recommendations made by the Organization for Economic Co-operation and Development’s
(“OECD”) Base Erosion and Profit Shifting (“BEPS”) project. The OECD continues to advance its work under the BEPS 2.0 initiative to develop the framework for Pillar Two,
which aims to implement a global minimum tax of 15%. Many countries have enacted or drafted legislation using the Pillar Two framework to propose domestic tax laws
requiring a minimum tax rate of 15% (“top-up tax”) on income earned in the respective countries. The tax liability from top-up tax may have a material and adverse impact to
our effective tax rate.
Our business would be harmed if we do not receive parts sufficient in number and performance to meet our production requirements and product specifications in a
timely and cost-effective manner.
We use a wide range of materials in the production of our products, including custom electronic and mechanical components, and we use numerous suppliers to supply
these materials. Generally, we do not have guaranteed supply arrangements with our suppliers. Because of the variability and uniqueness of customers’ orders, we do not
maintain an extensive inventory of materials for manufacturing. Through our business interruption planning, we seek to minimize the risk of production and service
interruptions and/or shortages of key parts by, among other things, monitoring the financial stability of key suppliers, identifying (but not necessarily qualifying) possible
alternative suppliers and maintaining appropriate inventories of key parts. Although we make reasonable efforts to ensure that parts are available from multiple suppliers,
certain key parts are available only from a single supplier or a limited group of suppliers. Also, key parts we obtain from some of our suppliers incorporate the suppliers’
proprietary IP; in those cases, we are increasingly reliant on third parties for high-performance, high-technology components, which reduces the amount of control we have
over the availability and protection of the technology and IP that is used in our products. In addition, if certain of our key suppliers experience liquidity issues and are forced to
discontinue operations, which is a heightened risk, especially during economic downturns, it could affect their ability to deliver parts and could result in delays for our products.
Similarly, especially with respect to suppliers of high-technology components, our suppliers themselves have increasingly complex supply chains, and delays or disruptions at
any stage of their supply chains

-- 51 of 62 --

Table of Contents
may prevent us from obtaining parts in a timely manner and result in delays for our products, or our suppliers might pass on the cost of inflation to us while we are unable to
adjust pricing with our own customers.
In April 2025, the Chinese government imposed export controls on seven of the seventeen elements classified as rare earth elements. In October 2025, the Chinese
government imposed additional restrictions and licensing requirements on certain rare earth elements, some of which became effective immediately on the announcement date
and other portions of the regulations became effective in November 2025. The Chinese government imposed export controls on an additional five rare earth elements and
certain license requirements for items made outside of China that incorporate controlled rare earth elements. It is estimated that China controls about 70% of the worldwide
mining of rare earth elements, 90% of the separation and processing of those elements and 93% of the magnets manufactured from those elements. Rare earth elements are
critical to certain components contained in our products. If our suppliers are unable to provide the components necessary to make our products because of restrictions placed on
their access to rare earth elements or products derived from rare earth elements, our business, financial condition and results of operations could be materially harmed. Our
operating results and business may be adversely impacted if we are unable to obtain parts to meet our production requirements and product specifications, or if we are able to
do so only on unfavorable terms.
A supplier may discontinue production of a particular part for any number of reasons, including the supplier’s financial condition or business operational decisions, which
would require us to purchase, in a single transaction, a large number of such discontinued parts in order to ensure that a continuous supply of such parts remains available to our
customers. Such “end-of-life” parts purchases could result in significant expenditures by us in a particular period, and, ultimately, any unused parts may result in a significant
inventory write-off, either of which could have an adverse impact on our financial condition and results of operations for the applicable periods. Recently, a few large suppliers
have discontinued manufacturing certain DRAM chips that are incorporated in a number of our products, and the resulting shortage has caused a dramatic increase in the prices
to acquire these chips. Our efforts to procure these chips have contributed to an increase in purchase commitments in fiscal 2026. We estimate that the additional costs to
procure these DRAM chips will continue to have an adverse impact on our gross margin in calendar 2026. If we are unable to acquire adequate supply of such chips or acquire
them in a timely or cost-controlled manner, our results of operations could be harmed.
ITEM 2. UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS
Equity Repurchase Plans
The following is a summary of stock repurchases for the three months ended March 31, 2026:
Period
Total Number of Shares
Purchased Average Price Paid per
Share
Total Number of Shares
Purchased As Part of
Publicly Announced Plans or
Programs
Approximate Dollar Value of Shares
that May Yet Be Purchased Under
the Plans or Programs
January 1, 2026 to January 31, 2026 	131,371 $ 	1,431.47 	131,371 $ 	3,750,463,056
February 1, 2026 to February 28, 2026 	190,647 $ 	1,405.79 	190,647 $ 	3,482,453,585
March 1, 2026 to March 31, 2026 	117,578 $ 	1,441.02 	117,578 $ 	10,313,021,679
Total 	439,596 	439,596
__________________
(1) Our Board of Directors has authorized a program that permits us to repurchase our common stock, including a $7.00 billion increase approved by the Board in the third
quarter of fiscal 2026. As of March 31, 2026, $10.31 billion remained available for repurchases under our repurchase program. All shares in the table were purchased
pursuant to our publicly announced repurchase program.
(2) Our stock repurchase program has no expiration date and may be suspended at any time. Future repurchases of shares of our common stock under our repurchase program
may be effected through various different repurchase transaction structures including isolated open market transactions, accelerated share repurchase agreements or
systematic repurchase plans, subject to market conditions, applicable legal requirements and other factors.
(3) Average price paid per share and approximate dollar value of shares that may yet be purchased under the plans or programs exclude the excise tax imposed on certain stock
repurchases as part of the Inflation Reduction Act of 2022, or other fees, costs or expenses that may be applicable to the repurchases.
ITEM 3. DEFAULTS UPON SENIOR SECURITIES
None.
(3) 	(1) 	(1)(2)(3)

-- 52 of 62 --

Table of Contents
ITEM 4. MINE SAFETY DISCLOSURES
Not applicable.
ITEM 5. OTHER INFORMATION
Rule 10b5-1 Trading Plans Adopted by Officers and Directors During the Third Quarter
During the three months ended March 31, 2026, the following officers of the Company adopted trading plans, or amendments to existing trading plans, to sell and/or gift
shares of our common stock that have been or will be issued upon the vesting of RSUs, or purchased in our Employee Stock Purchase Plan, that are intended to satisfy the
affirmative defense conditions set forth in Rule 10b5-1(c) under the Securities Exchange Act. The material terms of the trading plans other than pricing conditions are set forth
in the table below:
Name of Officer 	Title of Officer 	Date of Adoption 	Duration 	Maximum Number of Shares to
be Sold
Virendra Kirloskar 	Senior Vice President and Chief Accounting Officer 	February 18, 2026 	366 days 	1,759
Mary Beth Wilkinson 	Executive Vice President, Chief Legal Officer and
Corporate Secretary
February 2, 2026 	365 days 	11,343
(1) Due to pricing conditions in the trading plans, the number of shares actually sold under the trading plans may be less than the maximum number of shares that can be sold.
Shares sold under plans upon the vesting of performance-based RSUs where the performance conditions have not been met at the time of plan adoption or are to be purchased
in the future under our employee stock purchase plan are calculated at the maximum number of shares that may be issued, with fractional shares disregarded.
(2) For RSUs that have not vested, the maximum number of shares to be sold does not take into account shares withheld for taxes.
(3) Mr. Kirloskar’s trading plan terminates when the last trade is placed under the plan. The last scheduled trade is on August 7, 2026; provided that if any scheduled trades are
not placed because of trading conditions set forth in the plan, the trading plan will terminate on February 18, 2027.
(4) Ms. Wilkinson’s trading plan terminates when the last trade is placed under the plan. The last scheduled trade is on August 7, 2026; provided that if any scheduled trades are
not placed because of trading conditions set forth in the plan, the trading plan will terminate on February 1, 2027.
(1) (2)
(3)
(4)

-- 53 of 62 --

Table of Contents
ITEM 6. EXHIBITS
Incorporated by Reference
Exhibit Number Exhibit Description 	Form 	File Number
Exhibit
Number 	Filing Date
3.1 	Restated Certificate of Incorporation 	10-K 	No. 000-09992 	3.1 	August 16, 2019
3.2 	Amended and Restated By-Laws 	8-K 	No. 000-09992 	3.1 	November 7, 2025
10.1 	Calendar Year 2026 Executive Incentive Plan*+
31.1 	Certification of Chief Executive Officer under Rule 13a-14(a)/15d-14(a)
of the Securities Exchange Act of 1934
31.2 	Certification of Chief Financial Officer under Rule 13a-14(a)/15d-14(a)
of the Securities Exchange Act of 1934
32 	Certification of Chief Executive Officer and Chief Financial Officer
Pursuant to 18 U.S.C. Section 1350^
101.INS
XBRL Instance Document - the instance document does not appear in
the Interactive Data file because its XBRL tags are embedded within the
Inline XBRL document
101.SCH 	XBRL Taxonomy Extension Schema Document
101.CAL 	XBRL Taxonomy Extension Calculation Linkbase Document
101.DEF 	XBRL Taxonomy Extension Definition Linkbase Document
101.LAB 	XBRL Taxonomy Extension Label Linkbase Document
101.PRE 	XBRL Taxonomy Extension Presentation Linkbase Document
104 	Cover Page Interactive Data File (formatted as Inline XBRL and
contained in Exhibit 101)
^ Furnished herewith
* Denotes a management contract, plan or agreement.
+ Certain portions of this document that constitute confidential information have been redacted in accordance with Regulation S-K, Item 601(b)(10).

-- 54 of 62 --

Table of Contents
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly
authorized.
KLA CORPORATION
(Registrant)
April 29, 2026 	/s/ RICHARD P. WALLACE
(Date) 	Richard P. Wallace
President and Chief Executive Officer
(Principal Executive Officer)
April 29, 2026 	/s/ BREN D. HIGGINS
(Date) 	Bren D. Higgins
Executive Vice President and Chief Financial Officer
(Principal Financial Officer)
April 29, 2026 	/s/ VIRENDRA A. KIRLOSKAR
(Date) 	Virendra A. Kirloskar
Senior Vice President and Chief Accounting Officer
(Principal Accounting Officer)

-- 55 of 62 --

CERTAIN IDENTIFIED INFORMATION HAS BEEN EXCLUDED FROM THE EXHIBIT BECAUSE IT IS BOTH NOT MATERIAL AND WOULD LIKELY
CAUSE COMPETITIVE HARM TO THE COMPANY IF PUBLICLY DISCLOSED. OMISSIONS ARE DESIGNATED AS [**].
EXHIBIT 10.1
CY26 EXECUTIVE INCENTIVE PLAN
(Annual Executive Bonus)
Plan Summary
This KLA Executive Incentive Plan (the “Plan”) is intended to motivate senior executives to achieve short-term and long-term corporate objectives
by providing a competitive bonus for target performance and potential upside for outstanding performance.
Plan Period
This Plan is effective for the calendar year period from January 1, 2026, through December 31, 2026 (the “Plan Period”). Newly eligible
employees (e.g., employees promoted to an incentive-eligible position under this Plan for the first time or a new hire) must be in an eligible
position on or before October 1, 2026, as recorded in the HR system to qualify for participation in this Plan Period.
Eligible Positions
The Chief Executive Officer (“CEO”) of KLA Corporation (the “Company”) and employees of the Company and designated Company subsidiaries
(as identified in Addendum A hereto) holding a position at the X2 or F2 level and above (collectively, with the CEO, “Executives”) are eligible to
participate in the Plan.
Program Payments
Bonus payments, based on performance during the Plan Period, will be paid within 90 days following December 31, 2026. Bonus calculations
shall be based on paid base salary for the applicable Plan Period. Paid base salary includes base salary and seasonal bonuses paid in some
countries if the seasonal bonus is considered a component of the employee’s annual salary. Paid base salary does not include relocation
allowances and reimbursements, tuition reimbursements, car/transportation allowances, expatriate allowances, commissions, long-term disability
payments, or bonuses paid during the Plan Period. A participant must be a regular, active employee of the Company on the date of the payout to
receive payment. Employees who are promoted or hired into an eligible position during the Plan Period (on or before October 1, 2026) will have
their payouts calculated on paid salary from the effective date of the promotion or hire, as recorded in the HR system. If an employee’s target
bonus changes during the year, the payout will be prorated.
Target Bonus
A target bonus is established as a percent of base salary for each Plan participant.
Funding Threshold
Total available funding for the Plan will be determined by performance against a threshold level as measured by Balanced Scorecard and
Operating Margin (“OM”) * performance for the Plan Period. The Plan will be fully funded (equivalent to the dollar sum, for all Plan participants in
the aggregate, of two times the product of each Plan participant’s target bonus percentage and paid base salary during the Plan Period) upon
achievement of OM Performance of $[**]M. This fully
Effective January 1, 2026

-- 56 of 62 --

CERTAIN IDENTIFIED INFORMATION HAS BEEN EXCLUDED FROM THE EXHIBIT BECAUSE IT IS BOTH NOT MATERIAL AND WOULD LIKELY
CAUSE COMPETITIVE HARM TO THE COMPANY IF PUBLICLY DISCLOSED. OMISSIONS ARE DESIGNATED AS [**].
funded amount represents the maximum bonus opportunity for all Plan participants in the aggregate and the maximum total cost of the Plan.
Performance Matrix and Determination of Funding Available for Bonus Payments
The level of funding available for payment to participating Executives will be based on performance as measured against the Corporate Balanced
Scorecard and OM performance, as provided in the CY26 Executive Bonus Funding Table below. Amounts in the table represent the
applicable funding multiples. The total level of funding available will be equivalent to the dollar sum, for all Plan participants in the aggregate, of
the product of each Plan participant’s target bonus percentage and paid base salary during the Plan period multiplied by the funding multiple.
Individual Performance and Determination of Executive Bonus Payments
The actual bonus payment amount for each individual Executive (other than the CEO) will be based on the CEO’s assessment of the Executive’s
performance for the Plan Period and determination of the Executive’s bonus achievement as a percentage of the Executive’s bonus target. Each
Executive’s performance will be evaluated based on how effectively that Executive led his or her organization as demonstrated against the key
Balanced Scorecard measures and objectives for the Executive’s respective organization. The bonus achievement percentage and resultant
bonus payment for each Plan participant who is an executive officer of the Company for purposes of Section 16 of the Securities Exchange Act of
1934, as amended, with the exception of the CEO, will be recommended by the CEO and reviewed and approved by the Compensation and
Talent Committee. The bonus achievement percentage and resultant bonus payment for the CEO will be determined and approved by the
Company’s Board of Directors (with the CEO recusing himself). The bonus achievement percentage and final bonus payment for all other Plan
participants will be reviewed and approved by the CEO.
Effective January 1, 2026

-- 57 of 62 --

CERTAIN IDENTIFIED INFORMATION HAS BEEN EXCLUDED FROM THE EXHIBIT BECAUSE IT IS BOTH NOT MATERIAL AND WOULD LIKELY
CAUSE COMPETITIVE HARM TO THE COMPANY IF PUBLICLY DISCLOSED. OMISSIONS ARE DESIGNATED AS [**].
Bonus Calculation
The formula for a participant’s bonus calculation is:
Participant’s paid base salary for the Plan Period
x Participant’s target bonus percentage
x Participant’s bonus achievement percentage
= Participant’s bonus payout
In no event shall a bonus payment to a participant exceed two times such participant’s target bonus (i.e., two times the product of the
participant’s paid base salary for the Plan Period multiplied by the participant’s target bonus percentage).
General Provisions
The Compensation and Talent Committee (or the independent members of the Company’s Board of Directors (the “Independent Directors”))
shall be the Plan Administrator. The Compensation and Talent Committee (or the Independent Directors) shall make such rules, regulations,
interpretations, and computations and shall take such other action to administer the Plan as it may deem appropriate. The establishment of the
Plan shall not confer any legal rights upon any employee or other person for a continuation of employment, nor shall it interfere with the rights of
the Company to discharge any employee and to treat him or her without regard to the effect which that treatment might have upon him or her as
a participant in the Plan.
This Plan shall be construed, administered, and enforced by the Compensation and Talent Committee (or the Independent Directors), in its sole
discretion. The laws of the State of California will govern any legal dispute involving the Plan. The Compensation and Talent Committee (or the
Independent Directors) may at any time alter, amend, or terminate the Plan in its sole discretion.
This Plan is adopted pursuant to the KLA Performance Bonus Plan and sets forth the terms and conditions for the calendar year 2026 annual
incentive program for Executives.
* References in this Plan to Operating Margin refer to the Company’s calculation of non-GAAP Operating Margin
Effective January 1, 2026

-- 58 of 62 --

CERTAIN IDENTIFIED INFORMATION HAS BEEN EXCLUDED FROM THE EXHIBIT BECAUSE IT IS BOTH NOT MATERIAL AND WOULD LIKELY
CAUSE COMPETITIVE HARM TO THE COMPANY IF PUBLICLY DISCLOSED. OMISSIONS ARE DESIGNATED AS [**].
ADDENDUM A
Designated Subsidiaries List
1. KLA-Tencor (Singapore) Pte Ltd
2. KLA-Tencor International Trading (Shanghai) Co., Ltd.
Effective January 1, 2026

-- 59 of 62 --

Exhibit 31.1
Certification of Chief Executive Officer
Pursuant to Exchange Act Rule 13a-14(a)/15d-14(a) As Adopted
Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002
I, Richard P. Wallace, certify that:
1 I have reviewed this Quarterly Report on Form 10-Q of KLA Corporation;
2 Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements
made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
3 Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial
condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;
4 The registrant’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act
Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and
have:
(a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that
material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the
period in which this report is being prepared;
(b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to
provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with
generally accepted accounting principles;
(c) Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the
disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
(d) Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter
(the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s
internal control over financial reporting; and
5 The registrant’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the
registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):
(a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to
adversely affect the registrant’s ability to record, process, summarize and report financial information; and
(b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over
financial reporting.
April 29, 2026 	/s/ RICHARD P. WALLACE
(Date) 	Richard P. Wallace
President and Chief Executive Officer
(Principal Executive Officer)

-- 60 of 62 --

Exhibit 31.2
Certification of Chief Financial Officer
Pursuant to Exchange Act Rule 13a-14(a)/15d-14(a) As Adopted
Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002
I, Bren D. Higgins, certify that:
1 I have reviewed this Quarterly Report on Form 10-Q of KLA Corporation;
2 Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements
made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
3 Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial
condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;
4 The registrant's other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act
Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and
have:
(a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that
material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the
period in which this report is being prepared;
(b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to
provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with
generally accepted accounting principles;
(c) Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the
disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
(d) Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter
(the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's
internal control over financial reporting; and
5 The registrant's other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the
registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions):
(a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to
adversely affect the registrant's ability to record, process, summarize and report financial information; and
(b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over
financial reporting.
April 29, 2026 	/s/ BREN D. HIGGINS
(Date) 	Bren D. Higgins
Executive Vice President and Chief Financial Officer
(Principal Financial Officer)

-- 61 of 62 --

Exhibit 32
CERTIFICATION OF CHIEF EXECUTIVE OFFICER
PURSUANT TO
18 U.S.C. SECTION 1350,
AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
I, Richard P. Wallace, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that the Quarterly Report of KLA
Corporation on Form 10-Q for the fiscal quarter ended March 31, 2026 fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934
and that information contained in such Quarterly Report on Form 10-Q fairly presents in all material respects the financial condition and results of operations of KLA
Corporation.
April 29, 2026 	By: 	/s/ RICHARD P. WALLACE
(Date) 	Name: 	Richard P. Wallace
Title: 	President and Chief Executive Officer
CERTIFICATION OF CHIEF FINANCIAL OFFICER
PURSUANT TO
18 U.S.C. SECTION 1350,
AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
I, Bren D. Higgins, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that the Quarterly Report of KLA
Corporation on Form 10-Q for the fiscal quarter ended March 31, 2026 fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934
and that information contained in such Quarterly Report on Form 10-Q fairly presents in all material respects the financial condition and results of operations of KLA
Corporation.
April 29, 2026 	By: 	/s/ BREN D. HIGGINS
(Date) 	Name: 	Bren D. Higgins
Title: 	Executive Vice President and Chief Financial Officer

-- 62 of 62 --